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INTRODUCTION 
1 
GENERAL 
Alpha Macroglobulins (aMs) are a family of homologous 
proteins that occur in many animals including invertebrates, 
reptiles, birds and mammals. They share the ability to 
inhibit a vast array of proteinases irrespective of 
catalytic mechanism or substrate specificity (Barrett, 1981; 
Roberts, 1986; Sottrup-Jensen, 1987). The aMs belong to the 
thiol ester protein family comprising complement components 
C3, C4 and C5 (Sottrup-Jensen et al., 1984c & 1985; Lundwall 
et all., 1985). Rat 04M (Ganrot, 1973; Gordan, 1976; 
Lonberg-Holm et al., 1986), rat inhibitor III (Gauthier et 
al., 1978; Esnard et al., 1985 and Lonberg-Holm et al., 
1986), human pregnancy zone protein (PZP) (Smithies, 1959; 
Sottrup-Jensen et al., 1984c; Sand et al., 1985) and 
probably human pregnancy associated plasma protein A (Lin et 
al., 1974; Sutchliffe et al., 1980) also belong to this 
family. aMs have related primary structure and many of them 
share a characteristic internal activatable fl-cystemy1-T-
glutamyl thiol ester bond (Feinmann, 1983; Lonberg-Holm et 
al., 1986). 
a2 M functions as "molecular trap" for proteinases 
(Barrett and Starkey, 1973), and rather being regarded as 
proteinase inhibitors, the a2M should be actually considered 
a sophisticated binding protein activatable by specific 
limited proteolysis of a particularly exposed peptide 
stretch, the "bait region" (Barrett and Starkey, 1973; 
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Harpel, 1973). Following cleavage in the bait region, «2M 
undergoes large conformational change leading to the 
blockage of the proteinase by "trap" formation (Barrett and 
Starkey, 1973). When bound to o^M, a proteinase is largely 
"protected" from reaction with large molecular weight 
proteinases, inhibitors and substrates, but it continues to 
remain accessible to small molecular weight substrates and 
inhibitors (Ganrot, 1966; Barrett and Starkey, 1973). In the 
short lived "nascent" state, the activated internal Q-
cysteinyl-r-glutamyl thiol esters provide a potential for 
covalent binding of activating proteinases as well as other 
nucleophiles (Harpel et al., 1979; Sottrup-Jensen et al., 
1980; Howard et al., 1980). This is a major feature of the 
proteinase binding mechanism of o^Ms. Bait region cleavage 
also results in the exposure of previously concealed sites 
of the «2'v' that are recognized by the high affinity 
receptors present on the surface of several cell types (Van 
Leuven et al., 1979; Kaplan and Nielson, 1979). By binding 
to o^M, proteinases and perhaps other biological targets 
therefore become destined to rapid clearance and 
degradation. 
Among the various otMs, that derived from human blood 
has been most extensively studied. It was first isolated in 
1954 by Brown et al. who reported the isolation of a 
thermocoagulable «2_glycoprotein in crystalline form from 
Cohn's fraction III-O. Shultze and coworkers (1955) were the 
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first to designate the protein, on the basis of its 
electrophoretic mobility and high molecular weight, as o^M-
The most frequently cited early isolation and 
characterization is that of Schonenberger et al. (1958). 
They reported that o^M had a molecular weight of 820 to 950 
KDa by sedimentation and diffussion coefficient 
measurements, that its electrophoretic mobility was <X2 and 
it was a glycoprotein making up about one third of the <X2 
fraction of serum proteins and approximately IV. of the total 
serum proteins. o^M was first recognized as proteinase 
inhibitor in 1963 by Schultze et al. based on its ability to 
act as an inhibitor of plasmin. 
MOLECULAR STRUCTURE 
Most «Ms are tetramers but dimenc and even monomeric 
ocMs have been described (Starkey and Barrett, 1982; Stoker 
and Zwilling, 1986; Hergenhahm et al., 1988; Enghild et al., 
1989). Human 0C2M is a tetramer consisting of 185 KDa 
subunits (Harpel, 1973; Frenoy and Bourrillon, 1977; Hall 
and Roberts' 1978; Barrett et al., 1979). The subunits are 
chemically identical (Swenson and Howard, 1979a; Sottrup-
Jensen et al., 1979; Hall et al., 1981). Two subunit chains 
are covalently linked by disulphide bonds to form the 
protomers or the half molecules and two protomers are 
associated non-covalently to form the complete four subunit 
molecule (Harpel, 1973; Steinbuch et al., 1975; Barrett et 
al,, 1979t Roche et al., 1988). The four subunits are 
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organised to form two adjacent proteinase binding sites in 
the tetramenc molecule (Pochon and Beith, 1982; Sterner et 
al., 1985). Identical architecture is also seen in several 
0(2^ homologues found in other mammals and in the 
ovomacroglobulin from avian eggs (Nishigai et al., 1985; 
Ruben et al., 1988). The o^M homologues of fish, reptiles 
(Starkey and Barrett, 1982) and crustacean (Spycher et al., 
1987), however, are about half the size of human o<2M and 
their single inhibitory unit is composed of only two 
subun i ts. 
(a) The Bait Region : The human 0(21*1 subunits contain an 
exposed stretch of amino acids termed the bait region 
(Barrett and Starkey, 1973; Harpel, 1973). It is located 
near the middle of the polypeptide chain and is uniauely 
sensitive to cleavage by proteinases. Complex formation with 
a variety of proteinases is initiated by specific cleavage 
in this region and the sites of cleavage have been 
determined for many proteinases (Hall et al., 1981; Sottrup-
Jensen et al., 1981a; Mortensen et al., 1981; Virca et al., 
1983; Sottrup-Jensen and Birkedal Hansen, 1989). The segment 
is located between residues 666 and 706 in human o^M (Fig. 
1) and is flanked by segments of strongly conserved 
sequences. The sequence of bait region is however highly 
variable and the human protein contains only one cysteine 
(four residues in from the left) and no asparagine residues 
on to which a carbohydrate unit can be attached. Bait 
Figure 1 : Diagram of a subunit of o^M showing the 
relative positions of the functionally 
important regions. 
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region, thus, is free of protecting carbohydrate moieties 
and restricting disulfide bonds and meets the specificities 
of most endopeptidases known (Sottrup-Jensen et al., 1984b; 
Kan et al., 1985; Jensen and Sottrup-Jensen, 1986). 
Proteolysis generally occurs at residues which are 
compatible with the specificity of known proteinases 
(Mortensen et al., 1981; Virca et al., 1983; Roberts and 
Hall, 1983; Micheal et al., 1987; Sottrup-Jensen et al., 
1989). Evidently each bait region contains one or more 
peptide bonds which can be cleaved by a wide selection of 
proteinases. The identification of several adjacent or 
closely spaced cleavage sites of PZP suggests that random 
cleavage may occur in several cases (Sottrup-Jensen et al., 
1989). 
The sequence of the stretches of human PZP and rat aMs, 
presumed to function analogous to the human o<2M bait region, 
are of different lengths spaning 39 amino acids in human o^M 
(Sottrup-Jensen et al., 1984b; Kan et al., 1985; Jensen and 
Sottrup-Jensen, 1986), 49 amino acids in human PZP (Sottrup-
Jensen et al., 1984c; Sand et al., 1985), 53 amino acids in 
rat a^M, 32 amino acids in rat o^M and 52 amino acids in rat 
04I3 (Gehnng et al., 1987; Braciak et al., 1988; Aiello et 
al., 1988). The bait region sequence is the only dissimilar 
sequence in the aMs derived from different species (Micheal 
et al., 1987; Sottrup-Jensen et al., 1989). A reasonable 
advantage of sequence variation in the bait region would be 
7 
the emergence of specialized ocMs that inhibit specific 
subsets within the overall spectrum of proteinases (Sottrup-
Jensen et al., 1989). 
Bait region of ocMs contain several highly charged 
residues except in case of PZP where there are present only 
three. However, there appears no common pattern of charges 
in other regions except that there are present one or more 
negatively charged residues at COOH terminal boundary. This 
region of aMs is rich in glycine and proline residues, 
exception being rat o^M and rat 04I3 (Sottrup-Jensen et al., 
1989). 
There also exist no common patterns of a helices and 8 
sheets in various aMs (Sottrup-Jensen et al., 1989). Several 
bait regions contain clustered hydrophobic residues and the 
hydropathic plots obtained indicate the presence of a 
hydrophilic region seperating two hydrophobic segments 
spaced by 6-10 residues, (Roberts and Hall, 1983), largely 
corresponding to the two major areas of proteolytic cleavage 
(residues 681-686 and 696-700) identified in human 0(2^ 
(Mortensen et al., 1981). 
NMR studies of Gettins and Cunningham (1986); Arakawa 
et al., (1986) and primary structure analysis of 
Sottrup-Jensen et al. (1985) suggest that the bait regions 
of aMs are irregular and flexible structures in which 
relatively hydrophobic stretches are readily accessible to 
8 
cleavage. It is yet to be known whether the bait regions, 
inspite of their sequence diversity, assume a common gross 
structure. 
Spectroscopic studies of Gettins et al. (1988) suggest 
that the bait region of human o^M may be relatively compact, 
and it has been proposed from secondary structure 
predictions that the bait region forms a loop in which 
residues 680-685 and 695-700 form a short antiparallel B 
sheet, looping out from the 0C2M structure. Secondary 
structure analysis of aMs from other species (Sottrup-Jensen 
et al., 1989) however, do not indicate similar structure of 
bait region. 
(b) The Thiol Ester Bond Loop Region : aMs are 
characterized by the presence of an internal thiol ester 
bond, a character shared by complement components C3 and C4 
(Tack et al., 1980; Harrison et al., 1981; Sottrup-Jensen et 
al., 1985). The reactive internal fl-cyste m y 1-T-g lut amy 1 
949 thiol ester involves the thiol group of cysteine and a-
952 
carbonyl group of nearby glatamic acid residue (Fig. 2) 
(Sottrup-Jensen et al., 1980; Howard, 1981; Salvesen et al., 
1981). The thiol ester in the native protein is sensitive to 
nucleophilic attack at the carbonyl group of the glutamic 
acid residue by small primary amines such as methylamine and 
ammonia (Barrett et al., 1979; Howard et al., 1980; Salvesen 
et al., 1981; Feldman et al., 1984; Esnard et al., 1985). A 
Figure 2 : The thiolester bond loop of o^ PI and the 
formation of covalent bond between inhibitor 
and the proteinase. 
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similar nucleophilic attack by the amino group of glutamic 
acid residue on the oc-carbonyl group, cleaves the peptide at 
this site at elevated temperatures (Barrett et al., 1979; 
Harpel et al., 1979; Howard, 1981; Esnard et al., 1985). 
Rupture of the thiol ester bonds, after exposure to 
proteinases or primary amines, results in the generation of 
titrable thiol groups (Tack et al., 1980; Sottrup-Jensen et 
al., 1981a; Feldman et al., 1984) which in turn leads to 
covalent linkage of proteinase to the inhibitor through E-
lysy 1 (prote inase )-r-glutamy 1 (0C2M) crosslinks (Howard, 1981; 
Salvesen et al., 1981; Sottrup-Jensen et al., 1980; 1981a; 
Wu et al., 1981). 
The exact location of thiol ester within the tetramenc 
structure of o^M * s n o* known. In the subunit it is located 
949 952 
in a strongly conserved sequence -Cys -Gly-Glu-Glx 
situated roughly about two thirds of the distance from NH2-
terminal end (Tack et al., 1980; Harrison et al., 1981; 
Sottrup-Jensen et al., 1985). The access to the thiol ester 
is quite discriminatory in native 0C2M as seen from the low 
reactivity of a branched amine like dimethy 1 amine and of 
amines larger than n-butylamine (Larson and Bjork, 1984), 
and it is possibly located in a small hydrophobic pocket 
partly shielded from solvent (Larson et al., 1987; Gettins 
et al., 1988; Zhao et al., 1988). The four thiol esters of 
the monomer are likely to be seperated by at least 20 A 
(Gettins et al., 1988) but not more than about 50 A° 
11 
(Sottrup-Jensen et al., 1990). However, the functionally 
0 
important bait region is very close (11-17 A) to the thiol 
ester bond as reported by Gettins et al. (1988) or 20-25 A0 
as reported by Sottrup-Jensen et al. (1990) and may well 
form a compact loop of two strands of fl-sheet. Proteolytic 
cleavage anywhere in this loop disrupts the loop and is the 
common trigger for cleavage of the thiol esters and trapping 
of the proteinase. 
(c) The Receptor Recognition Site : A site termed the 
"receptor recognition site" becomes exposed following 
conformational change induced by cleavage of thiol ester 
bonds of o^M (Van Leuven et al., 1982a, b; Roche et al., 
1987b). This site contains epitopes of antibodies defining 
neoantigenic sites on o^M proteinase complex not expressed 
on native 0(2^ (Marynen et al . , 1981; Van Leuven et al., 
1981 and 1983). The receptor recognition site was initially 
thought to be located in a 138 residue C00H terminal domain 
obtainable by limited digestion of methylamine treated aMs 
(Van Leuven et al., 1986). 
Studies of Roche et al. (1988) have shown that a 
monoclonol antibody (7H11D6) directed against the epitope of 
the receptor binding domain is sensitive to Cis-DDP, and 
this antibody does not bind to the 20 KDa COQH terminal 
fragment suggesting that this domain is not the complete 
receptor recognition domain. However, results of Enghild et 
12 
al. (198?) have shown that the complete receptor recognition 
site is contained within approximately 250 amino acid 
residues upstream from the C00H terminal of each otM subunit. 
Digestion of ocMs with papain separates the platinum 
sensitive epitope of the receptor recognition site from the 
remainder of the sites located in the C00H terminal 20 KDa 
region of the molecule. 
The amino terminal sequence of this 20 KDa domain in 
human o<2M shows that proteolytic cleavage occurs at the CDOH 
terminal end of Lys . Cleavage of the receptor 
recognition site in other species (bovine o^M, r a t al^ ancl 
OC1I3) occurs within three amino acids of the Lys 
indicating that this region is highly exposed during 
cleavage reaction and most likely has a very similar 
conformation. The sequence around Lys of human o^M (Ile-
Leu-Pro-Glu-Lys-Glu-61u-Phe-Pro-Phe) is predicted as 
strongly hydropathic patch (Sottrup-Jensen et al., 1986) 
obviously due to four charged amino acids. This patch may 
constitute a reverse turn and thus might project out at the 
surface of o<2M a n d nence susceptible to proteolytic attack. 
Lysine in the subunit may function as a hinge by which 
the receptor domain, when expressed, moves relative to the 
bulk of 0C2M structure (Van Leuven et al., 1986). Breaking 
the thiol ester is necessary and sufficient to express the 
receptor recognition sites (Van Leuven et al., 1982a, b; 
Roche et al., 1987b). 
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The primary structure of COOH terminal 20 KDa fragment 
shows that Asp is glycosylated in human o<2M and in 
bovine o^M (Enghild et al., 1989). However, another point of 
1381 
glycosylat ion in bovine 0C2M 1 S a t A s n which is not 
present in human o^M. The overall amino acid sequence 
identity between all of the COOH terminal 20 KDa domains 
studied (human 0(2^, bovine o^M, rat 04I3 and 04M) was 75V. 
(Enghild et al., 1989). Two segments of extra ordinarily 
high identity corresponding to residues 1359-1376 and 1424-
1435 in the human o^M sequence suggests that the primary 
receptor recognition domain is located in one or both of 
1329 1444 these regions. There is a Cys -Cys disulfide bridge 
in receptor binding domain of human o^M- This disulphide 
bridge is conserved in bovine CL^N and rat «il3 but not in 
rat oc^ M (Enghild et al., 1989). It has been proposed that 
the interchain disulfide bond is required for binding of the 
human o^M COOH terminal 20 KDa fragment to the receptor 
(Sottrup-Jensen et al., 1986). In the 20 KDa fragment of the 
human o^M this bond is thought to be necessary to maintain 
the conformation around the primary receptor recognition 
site. Enghild et al. (1989) have proposed that in rat a^M 
1329 the two phenylalanine residues which substitute for Cys 
1444 
and Cys may stack, and thus stabilize a similar 
conformation sequence homology. Studies of Sottrup-Jensen et 
al. (1985) have shown that the domain containing receptor 
recognition site in human «2 M *s also present in C3 and C4 
14 
and it is speculated that these regions may, contain the 
receptor recognition determinants as well (Van Lenven et 
al., 1986). 
<d> The Transglutaminase Crosslinking Site : Most alls 
contain a transglutaminase crosslinking site adjacent to the 
bait region, which is involved in the clustering of membrane 
bound 0C2M protein complex and its endocytosis in a variety 
of cells (Imber and Pizzo, 1981; Mortensen et al., 1981). 
Available evidences indicate that the sequence of events 
leading to internalization and degradation of «2M proteinase 
complexes may be analogous to that of the low density 
lipoprotein (Strickland et al., 1990). 
(e) The Carbohydrate Chain : Human o^M i s a glycoprotein 
with a carbohydrate content of 9.43% of the total dry weight 
of the molecule (Dunn and Spiro, 1967). It contains 31 
carbohydrate chains per molecule. The carbohydrate units 
differ considerably in size and are attached to the 
polypeptide by glycosylamine linkage to asparagyl residue 
(Dunn and Spiro, 1967). Two points of attachment of these 
carbohydrate moieties have been identified; one in the thiol 
ester bond loop region and the other in the 20 KDa receptor 
binding domain (Enghild et al., 1989). 
MECHANISM OF PROTEINASE INTERACTION 
Alpha-2-Macroglobulins inhibit all four classes of 
proteinases and their broad specificity is related to a 
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unique mechanism of action that distinguishes them from 
other active site directed protein inhibitor of proteinases 
(Laskowski and Kato, 1980; Read et al., 198<b). The mechanism 
of inhibition of proteinases by ocMs is so profoundly 
different from that of other proteinase inhibitors that 
Laskowski and Kato (1980) questioned the designation of o<2M 
as an inhibitor in the chemical sense. In general, 
proteinase inhibitor have following properties; a) the 
inhibitor abolishes all enzymatic activity towards all 
substrates, b) the inhibition is strictly competitive, and 
c) a particular inhibitory site can only inhibit proteinases 
belonging to a single proteolytic class (as defined by 
Hartley, 1960) and frequently shown as even narrower range 
of specificity; 0C2M exhibits none of these. 
The mechanism of inhibition of proteinases analysed in 
greatest detail using human a^ and was first described by 
Barrett and Starkey (1973) and is referred to as the "trap 
hypothesis". The hypothesis proposes that o^M entraps the 
proteinase as it undergoes a conformational change as a 
result of proteolysis of a single peptide bond within the 
bait region. The actual bond cleaved depends on the 
specificity of the attacking proteinase. Only active 
endopeptidases can cause the conformational change leading 
to their inhibition by irreversible trapping (Barrett and 
Starkey, 1973). This entrapment interferes with proteolysis 
by stencally hindering the access of large molecular weight 
16 
substrates. Large molecular substrates or inhibitors of the 
enzyme are also unable to gain access in its enclosed 
environment (Harpel and Mossenson, 1973; Bieth et al., 1981; 
Gonias and Pizza, 1983b). The access of low molecular weight 
substrates or inhibitors is, however, not affected 
(Haverback et al., 1962; Ganrot, 1966, 1967; K a n e and 
Glaser, 1981). 
Following the proteolytic clip in the bait region of 
o<2M the thiol ester bonds are cleaved, releasing free -SH 
groups. This facilitates the attainment of entrapping 
conformation and covalent linkage of the proteinase at the 
Glx residue of the cleaved thiol ester bond (Fig. 3) 
(Salvesen and Barrett, 1980; Sottrup-Jensen et al., 1981). 
The extent of covalent linkages formed between the 
proteinase and the o^M varies from enzyme to enzyme 
(Salvesen and Barrett, 1980). The conformational change 
results in compacting of the molecule as determined by 
hydrodynamic studies (Gonias et al., 1982b; Bjork and Fish, 
1982) and small angle X-ray scattering techniques (Branegard 
et al., 1982; Osterberg and Malmenster, 1984). The 
compaction of the molecule can readily be demonstrated by a 
"slow" to "fast" shift in e1ectrophoretIC mobility in native 
PAGE (Barrett et al., 1979; Nelles et al., 1980). Yet 
another consequence of this conformational change is the 
exposure of the receptor recognition sites on the molecule 
which allow the rapid clearance of o^M-proteinase complexes 
Figure 3 : Reaction of amines with o^M (I) and heat/ 
alkali induced cleavage of the subunit chain 
(II) . 
*\ 
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from the circulation by a variety of cells. Following 
binding to the specific receptor sites present on the 
surface of hepatocytes (Glieman and Davidsen, 1986), 
monocytes (Straight et al., 1988), macrophages (Kaplan and 
Nielsen, 1979; Feldman et al., 1985), fibroblasts (Dickson 
et al., 1981), the o^M-proteinase complexes undergo 
endocytosis. in_ vivo clearance studies have shown that the 
half life of the circulating o^^-trypsin complex is only 2-
4 min timber and Pizzo, 1981) which is strikingly lower than 
that of native o^M. The unmasking of the receptor 
recognition site on the o^M is also accompanied by exposure 
of a neoantigenic site on 0.2^ which is recognized by 
monoclonal antibody (Marynen et al., 1981; Strickland et 
al . , 1988). The antibody does not react with native o^^ i3U^ 
blocks the receptor mediated endocytosis of ot2M-proteinase 
complex suggesting that the neoantigenic site is also the 
receptor binding site. 
Small primary amines like methylamine and ethylamine 
react directly with thiol ester bond in the absence of 
proteinases and render it inactive (Barrett et al., 1979; 
Sottrup-Jensen et al., 1980). This reaction results in the 
covalent incorporation of the amine into the inhibitor 
(Swenson and Howard, 1979) with the liberation of free -SH 
groups (Salvesen et al., 1981) and a conformational change 
in the molecule which is very similar, though not identical 
to that observed in case of the proteinase treated <x-,ti 
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(Barrett et al., 1979; Gonias et al., 19B2b; Bjork and Fish, 
1982). The amine transformed o^M is also recognized 
similarly by the cells of the hepatocytes and 
reticuloendothelial system and cleared away from the 
circulation in exactly similar fashion (Van Leuven et ai., 
1979; Imber and Pizzo, 1981; Glieman et al., 1983). 
SHAPE/MODEL 
Feldman et al. (1985) have presented a model of human 
o<2M that is compatible with most of the previous studies on 
the structure, function and phylogeny of the protein (Fig. 
4) . The model of the molecule resembles a hollow cylinder. A 
plane perpendicular to the axis of the cylinder and crossing 
halfway between the ends of the molecules seperates the 
inhibitor into two identical halves. Each half is made up of 
a ring with four arms (two per monomer projecting from one 
side). Each monomer is constituted of one long and one short 
arm. The other side of the ring makes contact with second 
functional half. Traping of the proteinases can occur by 
movement of one long arm per monomer, two arms per 
functional half. These long arms are termed as trap arms. As 
presented, the molecule has three 2-fold axes of symmetry 
(one through the axis of the cylinder and two perpendicular 
to it and each other in the median plane) and or no mirror 
planes consistent with the presence of four identical 
polypeptide chains. 
Figure 4 : Model of the three dimensional structure of 
<X2^ proposed by Feinman et al. (1982) showing 
"slow" and "fast" forms. 
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The proteinase binding sites are present on either side 
of the central rings aligned alongwith the central axis of 
the molecule. According to this model, the only 
conformational change required to affect a trap mechanism is 
a slight movement of the lateral arms of the molecule. 
Movement of the other 2 arms of the functional domain may 
occur but is not required for trapping in the model. It is 
postulated that the thiol ester bond is located near the 
hinge of the trap arms of each subunit. Cleavage of the 
thiol ester bond allows the trap arm to swing. In this 
model, reaction with amine can result in the same 
conformational change as that obtained by proteolytic 
cleavage of the bait region. The thiol ester within a pair 
are close together (at the base of adjacent trap arms 
separated by the plane between the functional halves), 
whereas the two pairs are located about 7 nm (the diameter 
of the ring in this model) apart. The model further predicts 
that there is one recognition site present on each subunit 
(one per trap arm and two per half molecule) located at the 
interface between functionally active halves. Trap closure 
results in the exposure of the receptor recognition sites at 
the base ring near each swinging arm of the trap. This model 
demonstrates one mechanism by which a large proteinase such 
as plasmin could not bind in 2:1 molar ratio (Gomas and 
Pizzo, 1983a, b ) . Protrusion of one of the domains of 
plasmin across the hollow core into the second binding site 
22 
could prevent sterically the binding of a second proteinase 
molecule. Reassoc1 at ion observed in case of trypsin treated 
half molecules is not seen after plasmin treatment as the 
same stenc hindrance preventing 2:1 proteinase to inhibitor 
binding in native o^M also prevents plasmin treated two 
halves from reassoc1 at ion. 
Liu et al. (1987) proposed alternative model of o^^' 
This model has many similarities with the model of Feldman 
et al. (1985). The essential feature of this model is that 
the subunits are arranged sequentially in an antiparallel 
manner around the main axis rather than in a bilateral 
pattern (Fig. 5) as proposed by Feldman et al. (1985). The 
subunit is a Z shaped structure with a short arm and a long 
arm, corresponding to the arms of the whole molecule. The 
authors further postulated that any active form requires 
that contacts be made between the enzyme binding sites and 
at least one of each of the arms. Alternatively, the binding 
sites are composed of parts of all four subunits and 
contribution from any two pairs are sufficient to retain 
some binding properties (Fig. 5 ) . Because the subunit 
polypeptide chains are antiparallel, the different half 
molecules do not present faces to the central axis, but 
depending on the orientation of critical side chains, the 
bound enzyme may see the same groups in the same orientation 
in both type of half molecules. An additional feature of the 
model is that since the bound enzyme is in proximity to all 
Figure 5 : Model of 0C2M proposed by Liu et al. (1987). 
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four subunits of the protein, there is an obvious mechanism 
for the negative cooperat1v1ty, which has been suggested for 
02^ reactions. 
Delain et al. (1988) have studied the three dimensional 
organisation of human o^M employing a panel of monoclonal 
antibodies by electron microscopy. Their results reveal that 
0(2^ has a rounded dough nut like shape with an excentered 
cavity or hole, some of the o<2M molecules have a regular 
more or less extended tetralobular structure which 
is in contradiction of what is proposed by Feldman et al. 
(1985). The "H" like structure represents the proteinase 
transformed or "fast" form of ot2M- Furthermore, the 20 KDa 
receptor binding domain is supposed to be present on the 
tips of the H formed o^M and not at the hinge region or the 
contact zone of the two half molecules. These domains are 
obscured, at least, partly, in native 0C2PI and the simple 
movement of the two "trap arms" (Feldman et al., 1985) 
cannot explain the expression of the receptor recognition 
site at the extremeties of the long arms. A change more 
complex than slight movement of the two trap arms per half 
molecule (Feldman et al., 1985) is therefore needed. 
This model further proposes that the globular domains 
of native a2M would unfold to build the lateral walls of the 
"H" to expose the receptor binding domains. In this scheme 
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the locations of the internal thiol ester bonds and the bait 
regions are not known. 
PHYSIOLOGICAL ROLE OF ALPHA-2-MACRQGL0BULIN 
The primary function of «2^ was thought to be a general 
scavenger of proteinases both endogenous to the host and 
those arising from infectious agents, thereby protecting 
blood and tissue proteins from unwarranted proteolytic 
attack. However, this well recognized proteinase inhibitory 
functions of <X2M are of uncertain physiological importance 
as virtually every endogenous mammalian proteinase, has a 
more specific and more rapidly acting inhibitor. 
Furthermore, o^M does not prevent various diseases resulting 
from deficiencies in these more specific proteinase 
inhibitors. For example, o^M shows significant anti-plasmin 
activity, while o<2-ant lp 1 asmin deficiency in the presence of 
normal levels of 0C2M is associated with hemorrhagic tendency 
(Saito, 1988). Antithrombin III deficient patients manifest 
a thrombotic diathesis (Bauer and Rosenberg, 1989) despite 
the inhibitory activity of o^M against factor Xa and 
thrombin (Sterner et al., 1985). It has not been determined 
whether o<2M limits the seventy of the clinical signs in 
these deficiency states. A number of workers have 
hypothesized the o^M-proteinase complexes may function as a 
reservoir of residual activity protecting the entrapped 
proteinase against inhibition by other circulating 
proteinase inhibitors. As o<2M can inhibit several of the 
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activated coagulation components and plasmin in the 
fibrinolytic pathway, it has been suggested that it may 
contribute in maintaining hemostatic, balance (Rinderknecht 
and Beokas, 1973). Studies of Multerz (1979) indicated that 
the main function of o^M in fibrinolytic process is to 
neutralize the sudden burst of plasmin generated in excess 
of the local amount of o<2 plasmin inhibitor present. Thus, 
in modulating the proteinase of coagulation cascade and in 
the regulation of fibrinolytic system, o^M seems to be 
relegated to a secondary role. Though the primary function 
of o^M is still unknown, it is clear that it plays some 
essential physiological role because complete o^M deficiency 
has not been detected and is, therefore, probably lethal 
(Laurell and Jeppssom, 1975). 
Specific roles for o^M have been suggested in 
modulating proteolytic cleavage of various peptide hormones 
(Rinderknecht and Geokas, 1973) other evidence suggests that 
0(2^ is important in modulating various immune responses as 
well as in the inflammatory responses (James, 1980). Hubbard 
et al. (1987) have shown that o^M acts as an 
immunosuppressive in its proteinase complexed formed. Recent 
studies have implicated o^M a s a significant binder, carrier 
and clearance protein for several physiologically important 
hormones, growth factors, interleukins, cytokines etc. 
(Huang et al., 1984; 0'Connor-McCourt and Wakefield, 1987; 
Huang et al-., 19SQI Banner et al,, 199ui James, 1990s La 
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Marre et al., 1990a and b ) . The significance of these 
interactions, though presently unclear are speculated to be 
related to the clearance of these peptides from the local 
environment via blood, lymph or locally via macrophages 
which express 0C2M receptors on their plasma membrane. Under 
circumstances where <X2M-cytok m e complexes are not rapidly 
cleared, the complex may act as reservoir of growth factors 
available to local or distant cells to elicit an appropriate 
biologic response (La Marre et al., 1991). 
The receptor mediated internalization of o^M proteinase 
is thought to represent a feed back mechanism which down 
regulates the release of proteinase. This is supported by 
the report of Johnson and his colleagues (1982) that <X2M 
proteinase complexes are capable of down regulating 
macrophage proteinase secretion, including a cytotoxic 
proteinase which is tumorocidal i_n_ vitro. 
EXPERIMENTAL 
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MATERIALS 
Chemicals used for the studies were obtained from the 
sources given against their names. Glass distilled water was 
used in all the experiments. 
Chemical Source 
Acetonitrile E.Merck, India. 
Acrylamide Sisco Research Lab., India. 
Agarose Sigma Chemical Co., USA. 
Ammonium persulphate May & Baker Ltd., England. 
Ammonium sulphate E.Merck, India. 
DL-Benzoyl arginine Sigma Chemical Co., USA. 
p-nitroanalide 
Blue dextran Pharmacia Fine Chemicals, 
Sweden. 
Bovine serum albumin Sisco Research Lab., India. 
Boric acid E.Merck, India. 
Bromophenol blue B.D.H., England. 
Coomassie brilliant blue Sigma Chemical Co., USA. 
R-250 
Concavalin A Sigma Chemical Co., USA. 
Cyanogen bromide Sisco Research Lab., India. 
Cysteine hydrochloride Centron Research Lab., India. 
O-Dianisidine V.P. Chest Institute, India. 
Diethylaminoethyl cellulose Sisco Research Lab., India. 
Dimethylsulfoxide Sarabai Chemicals, India. 
2,4,Dimtrosalysi1ic acid Sisco Research Lab., India. 
Ethanolamine B.D.H., India. 
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Fruend's Adjuvant 
Glycine 
Glycerol 
Horse radish Peroxidase 
Hydrogen peroxide 
Invertase 
0 - M e r c a p t o e t h a n o l 
N,N'-Methylene bisacrylamide 
Methyl a-D-mannopyranosidase 
PhenyImethylsulfonyl flouride 
Potassium persulphate 
Potassium thiocyanate 
Sephadex G-200 
Sephadex G-100 
Sepharose 4B 
Sodium dodecyl sulphate 
Sodium borohydride 
Sodium tetraborate 
Sodium tungstate 
Soyabean trypsin inhibitor 
Succinic anhydride 
Sucrose 
N,N,N'-N'-tetramethylene 
d i amine 
T n s (hydroxymethy 1 ) amino 
methane 
Difco Laboratories, U.S. 
E.Merck, Indla. 
B.D.H., India. 
Sisco Research Labs., In 
B.D.H., India. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
B.D.H., Eng1 and. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
B.D.H., India. 
B.D.H., India. 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
B.D.H., India. 
B.D.H., India. 
B.D.H., India. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
B.D.H., India. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
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2,4,6,Trimtrobenzens Sigma Chemical Co., USA. 
sulfonic acid 
Trypsin Sisco Research Labs., India. 
Freshly outdated human blood was collected from local 
Medical College. Plasma seperated by centrifugation was 
collected by aspiration. 
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METHODS 
I. PURIFICATION OF <x2 MACROGLOBULIN 
a) Ammonium Sulphate Fractionation : To 100 ml of outdated 
human blood plasma, 11.4 g of solid ammonium sulphate was 
added and dissolved by stirring at 4'C (20*/, saturation). 
After S h, the precipitate found was collected by centnfu-
gation at 5,000 rpm for 20 min and discarded. The 
supernatent was made 40'/. saturated with ammonium sulphate by 
adding further 12.3 g of the solid. The solution was again 
allowed to stand for 8 h and the precipitate recovered by 
centrifugation at 5,000 rpm for 20 min and dissolved in 20 
ml distilled water. Most of the o<2M activity present in 
blood plasma was found in the 20-407. pellet. The dissolved 
pellet was extensively dialysed against several changes of 
ice cold 0.1 M sodium phosphate buffer containing 0.1 M KC1, 
pH 8.0. 
b) Sephadex Column Chromatography : A column of Sephadex 
G-200 was prepared as recommended by Peterson and Sober 
(1962). The gel was allowed to swell in a suitable amount of 
distilled water for 5 h in a boiling water bath. A 
previously cleaned glass column was mounted vertically and 
glass wool plugged along with glass beads at the bottom of 
the column. The column was filled to one third of its length 
with operating buffer. The deaerated gel slurry was then 
gently poured with a help of a glass rod. The column was 
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left standing overnight. Flow rate was subsequently 
increased gradually with the help of stopcock. After 
accomplishing a constant rate of flow higher than that 
required for final elution, the column was adjusted to the 
required flow rate. The column was thoroughly washed with 
two bed volumes of operating buffer. In order to determine 
uniform packing and void volume of the column,3.0 ml of 2*/. 
(w/v) Blue Dextran was passed through the column. The buffer 
was carefully removed from the surface and protein sample 
applied. The volume of Blue Dextran and protein solution 
applied was not more than 2-3'/. of the total bed volume of 
the column. 
c) DEAE-Cellulose Chromatography : Appropriate aliquots of 
DEAE was suspended in 10 volumes of 0.5 N HC1 for 1 h and 
washed in a Buchner funnel. The washing was continued till 
pH of the filtrate was approximately 7.0. The exchanger was 
then treated with 10 volumes of 0.5 N sodium hydroxide for 1 
h and the washing continued till the pH of the filtrate 
approached neutrality. The DEAE-ce1lulose was then 
resuspended in operating buffer to get a homogenous slurry. 
Fine particles were removed and the slurry was poured in a 
clean vertically mounted jacketed column. The flow rate was 
gradually increased to 30 ml/h. The column was then 
equilibrated with the operating buffer. The buffer was 
carefully removed from the surface and protein sample 
applied. Protein in the flow was determined and the column 
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was washed with two bed volumes of the operating buffer. 
Elution was performed with a linear gradient (0-0.4 M NaCI) 
in 10 mM sodium phosphate buffer, pH 8.0. Five ml fractions 
were collected and assayed for enzyme activity and protein. 
Sodium chloride concentration in various fractions was 
determined by conductivity measurements. 
ASSAY PROCEDURES 
a) Protein Estimation : Protein was estimated by the 
method of Lowry et al. (1951). BSA was used as standard for 
the calibration curve. Suitable aliquots of protein 
solutions were diluted to 1.0 ml with buffer. To this was 
added 5.0 ml of freshly prepared copper reagent (prepared by 
mixing one part of 0.5*/. (w/v) copper sulphate in one part of 
1.0'/. sodium potassium tartarate and 50 parts of 2.0'/. (w/v) 
sodium carbonate in 0.1 N sodium hydroxide). 
After incubation at room temperature for 10 m m , 0.5 ml 
of 1 N Folin-phenol reagent was added and the tubes were 
instantly vortexed. Absorbance of the blue colour was 
measured after 30 min at 660 nm against a reagent blank in a 
Bausch and Lomb Spectronic 20 spectrophotometer. 
Protein in the column fractions were monitored at 280 
nm. 
b) Assay of Alpha-2-Macroglobulin : Alpha-2-macroglobulin 
activity was measured as its ability to protect the Trypsin 
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Protein Esterase activity (TPE-activ1ty) from SBTI, as 
described by Ganrot (1966). The esterase activity was 
measured essentially by the procedure of Erlanger et ai. 
(1961) with slight modifications. Appropriate amounts of 
inhibitor was diluted to 1.0 ml with 0.01 PI sodium phosphate 
buffer, pH 8.0. To this was added 0.1 ml of 0.1'/. trypsin 
(prepared in 0.0025 N HC1). After incubation at 37°C for 10 
min, 0.1 ml of 0-1*/. STI (prepared in 0.0025 Mmol) was added 
and incubated for 10 min. The volume of 0.8 ml buffer and 
2.0 ml of freshly prepared BAPNA solution (prepared by 
dissolving 43.5 mg BAPNA in 1.0 ml DPIS0 and then the 
solution was brought to 100 ml with buffer) were added, 
after which the samples were incubated at 37°C for 30 min. A 
blank without trypsin but otherwise identical was incubated 
simultaneously. The reaction was stopped by addition of 0.5 
ml of 30'/. acetic acid and the absorbance of the yellow 
coloured p-nitroanalide formed was determined at 410 nm. The 
amount of substrate hydrolysed by the enzyme was calculated 
using a molar extinction coefficient of 8800 PI cm for p-
nitroanilide at 410 nm. 
c) Assay of Peroxidase : Peroxidase was assayed by 
measuring the rate of oxidation of o-dlanisidine by hydrogen 
peroxide using the two substrates in saturating 
concentrations (Ugarova et al., 1979). To 2.3 ml of 0.01 PI 
sodium phosphate buffer, pH 7.0, was added 0.07 ml of 21 mPl 
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H2O2 and 0.07 ml o-dianisidine and 0.05 ml appropriately 
diluted enzyme solution. The increase in the absorbance at 
460 nm, after intensive stirring of the mixture (^460 = 
30,000 M cm ) for the product of oxidation was recorded 
by Baush and Lomb Spectronic 21 Spectrophotometer. A 
quantity of o-dianisidine (pmole) oxidized per min was taken 
as the measure of the enzyme activity. One unit of enzyme 
activity is pmoles of o-dianisidine oxidized per min. 
d) Assay of Invertase : Invertase activity was determined 
by the method of Goldstein and Lampen (1975). The reaction 
mixture contained in a total volume of 0.3 ml, 100 \il of 
0.2 M acetate buffer, pH 4.9, 10-100 pi of enzyme and 100 pi 
of 0.5 M sucrose solution. The assay mixture was incubated 
at 37°C for 10 min and the reaction was terminated by 
addition of 0.2 ml of 0.5 M phosphate buffer, pH 7.0, 
immediately followed by heating for 3 min in a boiling water 
bath. Addition of phosphate buffer before the heating 
markedly slowed down the reaction and rendered the enzyme 
more sensitive to heat treatment. The tubes were cooled and 
0.5 ml of distilled water was added. Glucose liberated was 
determined by adding 1.0 ml of DNS reagent and kept in 
boiling water bath for 5 min. Again 3.0 ml of distilled 
water was added and the color was read at 540 nm. One unit 
of invertase is the amount of enzyme which hydrolyses 1.0 
pmole of sucrose to glucose and fructose at pH 4.9. 
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e) Iron Estimation : Iron estimation was essentially done 
as described by Oser (1971) with slight modification. 
Protein in a total volume of 166 pi was mixed with 166 pi of 
concentrated sulphuric acid and the contents were vigorously 
mixed. Saturated potassium per sulphate (30 pi) was then 
added and the solution was again thoroughly mixed and 
diluted with sodium tungstate. Finally 0.3 ml of 3 N 
potassium thiocyanate was added and the colour was 
immediately read at 550 nm. Ferric ammonium sulphate was 
used for preparation of standard curve. Iron concentration 
was converted into peroxidase concentration with a help of 
separate calibration curve. Calibration curve was 
constructed by simultaneously determining the protein 
concentration and iron concentration in various aliquots of 
standard peroxidase solution. 
IMMOBILIZATION AND RELATED PROCEDURES 
a) Immobilization of Proteins on Sepharose 4B : Trypsin 
and Con A were immobilized on Sepharose 4B. The gel was 
activated as described by Porath et al. (1967). Five grams 
of Sepharose was washed thoroughly with distilled water in 
sintered glass funnel. The gel was sucked dry and suspended 
in 5.0 ml of distilled water and 5.0 ml of 2 M Na2C03 was 
added and mixed thoroughly by placing on a magnetic stirrer. 
One gram cyanogen bromide dissolved in 1.0 ml of 
acetonitnle was added to the breaker containing Sepharose 
and mixed thoroughly in cold for 10 min. The whole mass was 
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then transferred immediately to a glass sintered funnel and 
washed successively with 0.1 M bicarbonate buffer, pH 8.5, 
distilled water and once again with the buffer. After 
thorough washing the activated Sepharose was dried and 
resuspended in 5.0 ml of 0.1 M bicarbonate buffer, pH 8.5. 
Required amount of trypsin or Con A were dissolved in the 
same buffer and stirred with cyanogen bromide activated 
Sepharose for 24 h in cold. The Sepharose bound protein was 
separated by centrifigation and protein in the supernatent 
was quantitated in order to calculate the amount of protein 
immobilized. The protein matrix was thoroughly washed with 
0.1 M sodium bicarbonate buffer, pH 8.5 containing 1 Fi 
sodium chloride and then with 0.1 M sodium acetate buffer, 
pH 4.5 and again with 0.1 M sodium bicarbonate buffer, pH 
8.5. The washed suspension was treated with 0.1 ml of 98'/. 
ethanolamine for 2 h at 4°C The matrix was then washed with 
0.1 N sodium bicarbonate, pH 8.5. containing 1 M sodium 
chloride, distilled water and finally with the buffer. 
b) Activation of Sepharose Bound Con A : Matrix bound Con 
A was activated by the method of Y a n v et al. (1968). The 
Con A bound matrix was suspended in 0.1 M bicarbonate buffer 
pH 6.8 containing 0.001 M MnCl2, 0.001 M MgCl2, 0.001 M 
CaCl2 and 0.1 M NaCl and stirred for 12 h in cold. 
c) Succinylation of Con A Sepharose : 
Succinylation of Can A Sepharose was done essentially 
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according to the method described by Klotz (1967). Five 
grams of Con A Sepharose matrix was suspended in 15.0 ml of 
0.1 M bicarbonate buffer pH 8.0. The beaker containing the 
matrix is kept in ice and placed on a magnetic stirrer. 
Glass electrodes were placed in the suspended Con A matrix, 
and the pH adjusted to 8.0 with 0.1 M NaOH. Solid succinic 
anhydride was then added in small increments to the Con A 
Sepharose matrix over a period of 15 min to 1 h. With each 
addition of anhydride a drop in the pH was observed. The pH 
was adjusted to 8.0 by the addition of small amount of 
0.1 M NaOH. After all the anhydride has been added the 
solution was allowed to stand for about 30 min. 
d) Amino Group Estimation of Succinylated Con A Sepharose: 
Estimation of reactive amino groups in the matrix after 
succinylation was performed by TNBS method of Failla and 
Santi (1973) using plain Sepharose 4B and Con A Sepharose as 
controls. To the appropriately diluted matrix suspension 25 
pi of 0.3 M TNBS and 10 ml of 0.1 M Na2B404 (pH 9.0) were 
added. After agitation for 2 h, the mixture was centnfuged 
and the matrix washed with water until washings showed no 
absorbance at 420 nm. The packed matrix was diluted to 5.0 
ml with 50V. (v/v) acetic acid and dissolved by heating at 
75°C for 2 h. The absorbance was recorded at 420 nm in Baush 
and Lomb Spectronic 20 Spectrophotometer. 
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POLYACRYLAMIDE BEL ELECTROPHORESIS 
SDS-PA6E was performed essentially, according to the 
method of Laemmli (1970) using slab apparatus manufactured 
by Biotech India. Concentrated stock solutions were mixed in 
the appropriate order and proportions to give a final 
acrylamide concentration of 7.5'/.. It was then poured into 
the mold formed by two glass plates (8.5 x 10 cm) separated 
by 1.5 mm thick spacers. Bubbles and leaks were avoided. A 
comb providing a template for 7 sample wells was inserted 
into the stacking gel solution before polymerization began. 
When the polymerization was complete in about 30 min, the 
comb was removed and wells were overlaid with the running 
buffer. Samples containing 10-20 pg of protein mixed with 
equal volume of sample buffer (containing 10'/. sucrose, 
0.062 M T n s HCl pH 6.8, 27. SDS, bromophenol blue and when 
necessary 57. fi-mercaptoethanol ) were applied to the wells of 
the slab gel. Electrophoresis was performed at 100 V till 
the tracking dye reached the bottom of the gel. After the 
electrophoresis was complete, the gel was stained for 
protein in 0.17. Coomassie Brilliant Blue R-250, 107. acetic 
acid, 407. methanol solution for 2-3 h. Excess dye was 
removed by destaining the gel in solution containing 77, 
acetic acid, and 107. methanol. 
PAGE was performed essentially, according to the method 
of Laemmli (1970). 10-20 M9 of protein samples containing 
107. sucrose in 0.062 M Tns-HCl buffer pH 6.8 and 
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bromophenol blue, were e lectrophonsed on 5% gels in Tris-
Glycine buffer pH 8.3. 
Whenever required, PAGE was also performed as described 
by Van Leuven et al. (1982). A discontinuous buffer system 
was used. Reservoir buffer (lower and upper) was 41 mM-
Tns/40 mM borate buffer, pH 8.6; stacking gel was 4'/. poly-
acrylamide in 54 mM-Tris/20 mM H2SO4 buffer, pH 6.1; 
separating gel of 5% acrylamide was in 95 mli Tris HC 1 
buffer, pH 5.7. Samples were prepared in reservoir buffer 
containing 10'/. (v/v) glycerol. Gels were run for 3 h at 125 
V and stained in the same manner as described above. 
IMMUNOLOGICAL PROCEDURES 
a) Immunization of Rabbits : Antibodies against a^ were 
raised in healthy female albino rabbits. 200 \iq of electro-
phoretically pure o^P' in 0.5 ml of normal saline alongwith 
equal volume of Fruend's complete adjuvant was injected 
subcutaneously. Two weeks later 100 pg more of o^^1 w a s 
injected alongwith Fruend's incomplete adjuvant. A similar 
second booster was given in the third week and the animal 
was bled after an additional one week. The blood collected 
was allowed to coagulate at 22°C for 3 h. The antisera was 
decomplemented at 57°C for 30 min and stored at -10'C in 
smal1 allquots. 
b) Immunodiffusion : Immodiffusion was performed 
essentially by the method of Ouchterlony (1962). One percent 
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molten agarose in normal saline containing 0.2."/, sodium azide 
was poured on clean glass slides and allowed to solidify at 
room temperature. Required number of wells were cut from 
agarose and the slides were stored at 4°C. 4-10 \x\ of 
suitably diluted antisera and required amount of antigen 
prepared in normal saline were added in different wells. The 
reaction was allowed to proceed for 12-24 h in a moist 
chamber at room temperature. The slides were immersed in 
normal saline to remove any non-specific precipitin line. 
The agarose gels were dried by placing moist filter paper 
over the slides to obtain thin films of dried agarose stick 
to the glass slides. Staining was done in 0.2'/. Coomassie 
Blue in 25*/. isopropyl alcohol and 10'/. glacial acetic acid 
for 10 min. Destaining was performed by several washes with 
10'/. glacial acetic acid. 
RESULTS 
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PURIFICATION OF ALPHA-2-MACROGLOBULIN 
The purification procedure used in the present studies 
is based on that of Miyata et al. (1981) with some 
modifications. Human plasma proteins precipitated between 
20-40% ammonium sulphate saturation were dissolved in 0.1 M 
sodium phosphate buffer, pH 8.0 containing 0.1 M KC1, and 
dialysed extensively against the same buffer. This resulted 
in 2 fold purification and 80V. yield (Table 1). Figure 6 
shows the elution profile of the ammonium sulphate 
fractionated protein on Sephadex G-200 column. o^M was 
eluted at the void volume as the first protein peak followed 
by a second peak lacking (X2M activity. The pooled o^M 
fractions exhibited 33-fold enrichment in specific activity 
and contained 50% of the original activity. The Sephadex 
chromatographed sample was finally subjected to ion exchange 
chromatography on a DEAE cellulose. o<2M eluted as a sharp 
protein peak at the NaCl concentration of 0.07 to 0.08 M 
followed by small protein peak which showed no o^M activity 
(Figure 7 ) . The pooled fraction contained 28% of the 
original activity with 56-fold enrichment in specific 
activity. Purification of o^M is summarized in Table 1 and 
o<2M preparation thus obtained was highly active and showed 
specific activity of 5.6 p moles of p-nltroanalide formed 
per mg of protein. 
Figure 6 : Sephadex G-200 Gel Filtration 
The ammonium sulphate precipitated proteins 
obtained from 100 ml of plasma were dissolved 
in 25 ml of 0.1 ("1 sodium phosphate buffer, pH 
8.0 containing 0.1 M KC1 and dialysed 
extensively against the same buffer at 4°C. 
The dialysed sample was then loaded on 
Sephadex G-200 column (2.5 x 90 cm). The 
column was operated at a rate of 20 ml/h. 
Fractions of 5.0 ml were collected and 
assayed for 0C2M and protein concentration. 
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Figure 7 : DEAE-Cellulose Chromatography 
Fractions containing 0C2M activity collected 
from Sephadex G-200 were pooled, concentrated 
and dialysed extensively against 10 mfl sodium 
phosphate buffer, pH 8.0 and applied on DEAE 
cellulose column (2.5 x 30 cm). After 
thorough washing of the column, it was eluted 
with a linear gradient of 0 to 0.2 M NaCl in 
10 mM phosphate buffer pH 8.0. Elution was 
performed at a flow rate of 30 ml/h and 3.0 
ml fractions were collected. The fractions 
were screened for 0C2M activity, protein and 
conductance. 
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TABLE - 1 
P u r i f i c a t i o n o f Human a^M 
Preparation Total Total Total Specific Yield Punfi-
Voluw Activitv Protein Activity cation 
(•1) (Units ) (ag ) (Units/ag) X (fold) 
Crude 
20-40X AMoniua 
Sulphate precipi-
tate 
100 
40 
740 
589 
6950 
2677 
0.10 
0.22 
100 
79 
1 
2 
Sephadex 6-200 110 372 112 3.31 50 33 
DEAE Cellulose 25 207 37 5.6 28 56 
Determined by the method o f Lowry e t a l 
( 1 9 5 7 ) . 
One U n i t i s p moles o f p n i t r o a n a l i d e 
formed per m inu te at 37°C, 
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Purification of o^M preparation was also followed by 
polyacrylamide gel electrophoresis performed in presence and 
absence of SDS. Whole plasma and ammonium sulphate 
fractionated sample show a faint a2 M band, a slower moving 
band and several fast moving bands (Fig. 8 lanes a, b; Fig. 
9 lanes a, b ) . On purification through a Sephadex G-200 
column, a distinct 0C2M band and few fast moving bands were 
obtained (Fig. 8 lane c; Fig. 9 lane c ) . These additional 
bands were removed after DEAE cellulose chromatography and 
the purified preparation gave a single band (Fig. 8 lane d; 
Fig. 9 lane d> in non SDS electrophoresis and to o^^ monomer 
in SDS electrophoresis. 
MOLECULAR WEIGHT OF ALPHA-2-MACR06L0BULIN 
In order to conform the molecular weight of the (X2^ 
preparation isolated, a SDS-PAGE of the sample was run with 
human RBC membrane proteins as markers. The RBC membrane was 
prepared by hypotonic lysis of the cells as described by 
Fairbanks et al. (1971). As evident in figure 10(a), an a2 M 
subunit band is present at a position slightly below Band 2 
of the RBC membrane. The molecular weight of 0C2M subunit was 
calculated from its mobility by the procedure of Weber and 
Osborn (1969). The mobilities of RBC membrane proteins were 
plotted against the logarithm of their molecular weight 
CFig. 10(b)], Least square analysis of the data indicated a 
linear relationship between log M and relative mobility 
(Rm). The position of migration of «7M subunit corresponded 
Figure 8 : PAGE of Different Fractionation Steps of QL^ 
Purification 
The electrophoretic patterns of different 
preparations of oc2M *n 5'/. non-denaturing gels 
are shown. Ten to fifteen microgram of each 
preparation was e1ectrophoresed on the mini 
slab gel at room temperature using a current 
of 50 V. 
Lane a - human plasma 
Lane b - 20-40'/. ammonium sulphate fraction 
Lane c - Sephadex G-200 fraction 
Lane d - DEAE cellulose fraction. 
d 
Figure 9 : SDS-PAGE of Different Fractionation Steps of 
a^n Purification 
The electrophoretic patterns of different 
preparations of 0C2M in 7.5*/. SDS gels are 
shown Ten to fifteen microgram of each 
protein sample were loaded on a mini slab gel 
and e lectrophor>rsed at room temperature using 
a constant current of 50 V. 
Lane a - human plasma 
Lane b - 20-40*/. ammonium sulphate fraction 
Lane c - Sephadex G-200 fraction 
Lane d - DEAE cellulose fraction. 
( a ) 
2Ac k4 | 
l<\ I R -
RELATIVE MOBLITY 
Figure 10(a): SDS-PAGE of a^n and RBC Membrane 
The purified o^N w a s incubated with sample 
buffer containing 0.4'/. SDS and IV. Q-
mercaptoethanol at 37"C for 45 min. The RBC 
membrane sample was heated in a boiling 
waterbath for 3 min. The gel was run at 100 V 
at room temperature. 
Lane a - Human RBC memebrane 
Lane b - Human c^^ subunit 
(b): Molecular Weight Determination of o^M 
The molecular weight of the RBC membrane 
indicated are those reported by Haest et al. 
(1978). The relative mobility of the membrane 
proteins were plotted against their molecular 
weight using a least square analysis. 
' ^ ^ 
a b e d 
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to a molecular weight of 190 KDa which is slightly higher 
than the reported value (185 KDa). 
TRYPSIN TREATMENT OF ALPHA-2-MACROBLOBULIN 
Purified «2^ treated with two fold molar excess trypsin 
for 10 min at 37°C showed the characteristic "slow" to 
"fast" transformation in non-denaturing polyacrylamide gel 
electrophoresis performed using 5V. gels <Fig. 11). A similar 
increase in the electrophoretIC mobility was also observed 
when a2 M w a s exposed to Sepharose linked trypsin for 2 h at 
37°C. 
ENTRAPMENT OF HRP AND INVERTASE IN ALPHA-2-MACR0GL0BULIN 
Entrapment of HRP in o^M was attempted with the help of 
either soluble or Sepharose bound trypsin. For this purpose, 
a five fold molar excess of HRP was mixed into o^M and the 
mixture incubated with either soluble or immobilized 
trypsin. To the preparation containing soluble trypsin was 
added excess SBTI to inhibit free trypsin; immobilized 
trypsin was removed by centrifugation. Figure 12 shows the 
elution profile of the o^M exposed to either soluble or 
immobilized trypsin in the presence of HRP. Samples of 
native o^M a n d HRP were also passed through the column for 
comparison. Both native and trypsin transformed o^M were 
excluded from the Sephadex G-100 and eluted at the void 
volume of the column. HRP emerged from the column with the 
elution volume of 125 ml and the peak was clearly separated 
Figure 11: Electrophoresis of Native and Trypsin Transformed 
ot2M 
Purified o<2M was incubated with 2 fold molar 
excess of trypsin for 10 min at 37"C or with 
Sepharose bound trypsin for 2 h also at 37°C. 
Soluble trypsin was inactivated by addition 
of 1 mM PMSF while immobilized trypsin was 
removed from the reaction mixture by 
centnf ugat ion. A 5'/. non SDS gel was 
polymerized and 10 jjg of protein was applied 
on each lane. 
Lane a - native o^M 
Lane b - o^M incubated with soluble trypsin 
Lane c - 0C2M incubated with insoluble trypsin 
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from that of (X2^' Two protein peaks were obtained in the 
samples treated with soluble trypsin; the first eluting at 
the void volume, exhibited both HRP and BAPNA hydrolyzing 
activity and the second peak showed only HRP activity. Only 
a trace amount of HRP was associated with o^M w hen the two 
were incubated in the absence of trypsin, clearly indicating 
the proteolysis dependence of HRP association with o<2M. In 
the samples treated with immobilized trypsin the fraction of 
HRP eluting at void volume almost doubled, yet no BAPNA 
hydrolysing activity could be detected. 
Entrapment of invertase in o^M was achieved by 
employing a similar strategy. A five fold molar excess 
invertase was premixed with o^M and exposed to the 
immobilized trypsin for 2 h at 37°C. After removing the 
proteinase by centrifugation, the mixture was passed through 
Sephadex G-200 column. 
Two protein peaks were eluted from the column, one at 
the void volume and the other with an elution volume of 94 
ml (Fig. 13). The fraction eluting at void volume presumably 
corresponding to o^M did show significant invertase 
activity. However, no invertase activity could be detected 
in the void volume and the enzyme eluted in later 
fractions, when o^M invertase mixture not exposed to the 
proteinase passed through the column. 
1 
I 
Figure 12 : i Entrapment of HRP in at2M 
! i '.J 
! A Sephadex G-100 column (1.7 x 90 cm) was 
packed and equi11ibrated with 20 mM phosphate 
i buffer, pH 8.0. Samples containing pure oc2M 
• or peroxidase or their mixtures treated with 
• either ^oluble or Sepharose bound trypsin 
• were,1 passed through the column under 
i • • 
r \ 
• identical Iconditions and the column monitored 
: f or jHRP ( to ) and BAPNA-lytic activity ( x ) 
as well as for protein ( o ). Elution profile 
' !"of ('.A ) pure 0C2M and (B) HRP. The elution 
| profile of 02M incubated with five fold molar 
! excess HRP.in the presence of trypsin for 15 
, min .'at pH 8.0 is given in ( C |, ( D ) 
/ ' ' < 
• Elusion profile of o^M HRP mixture .incubated 
as. in ( C ) except that Sepharose bound 
trypsin replaced the soluble enzyme and the 
; sample, was incubated for 2 h. 
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Figure 13 : Entrapment of Invertase in ct-^\ 
Alpha-2-macroglobulin invertase complex 
exposed to immobilized trypsin were passed on 
Sephadex 6-200 column (1.2 x 90 cm) Elution 
was performed at a flow rate of 20 ml/h and 
3.0 ml fractions collected. Protein ( o ) and 
invertase activity ( a ) was determined in 
each fraction., ( A ) shows the elution 
profile of pure o^M anc* ^ ^ * represents the 
profile of invertase while ( C ) is the 
elution profile of o^ PI mixed with 5 fold 
molar excess of invertase exposed to 
insoluble trypsin for 2 h at 37°C. 
70 85 100 
ELUTION VOLUME (ml) 
115 130 
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The yields of HRP and invertase entrapment in o^M were 
calculated by measuring enzyme activity and protein in the 
peak fractions. Enzyme activity was converted to moles of 
enzymes using specific activity of the soluble enzyme. Table 
2 shows that the maximum enzyme: o^M molar ratio achievable 
with HRP is 1.8:1 while with invertase it was 0.8:1. The 
entrapment yield for HRP was only 1.2:1 when soluble trypsin 
was used for bait region cleavage. Entrapment yield of HRP 
was also calculated by estimating the iron content of the 
enzyme. Iron estimated in the peak fraction was converted to 
moles of enzyme using a calibration curve plotted as 
described under "methods". The values of 1.8:1 (Table 2) 
obtained for enzyme to o^M ratio very well corresponded to 
that obtained by enzyme activity measurements. 
IMMUNOPRECIPITATION OF ALPHA-2-MACR0GL0BULIN TRYPSIN 
COMPLEXES 
To beable to rapidly quantitate o^M associated enzyme, a 
simple immunopreclpitat ion procedure was developed. 
Antibodies were raised against purified o^M in albino 
rabbits by injecting the protein alongwith Fruend's 
adjuvant. The decomplemented antiserum is capable of 
reacting with native as well as trypsin transformed o^M as 
evident from the formation of clear precipitin lines on 
immunodiffusion (Fig. 14). In order to establish the ability 
of the antiserum to quantitatively precipitate trypsin 
transformed a7M, purified a^M was incubated with 3-fold 
Figure 14: I MHinodif fusion of Native and Trypsin 
Transformed o^M 
Purified ot2M was treated with soluble or 
immobilized trypsin as described in the 
legend to figure 11. Immunodiffusion was 
carried out on glass slides as described by 
Ouchterlony (1962) and stained as described 
in Methods. The central well contains rabbit 
anti o^M, (a) native o^M* <t>> trypsin treated 
o^M, and (c) immobilized trypsin treated 
«2M. 
• Or 
\ i> 
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molar excess of trypsin at 37"C for 10 m m . Excess trypsin 
was inhibited by the addition of SBTI. The o<2M trypsin 
complex so prepared was precipitated by the addition of 
increasing amounts of antiserum at 10'C for 8 h. About 50 pi 
of antiserum was capable of nearly quantitative 
precipitation of 300-350 jig of o^M in a total volume of 1.0 
ml containing 20 mM phosphate buffer, pH 8.0 (Fig. 15). 
Further increase in the amount of antiserum did not increase 
the <X2M precipitation. A good correlation between the o^M 
protected trypsin activity, measured using BAPNA as 
substrate, lost from the supernatant and that appearing in 
the precipitate after the addition of various amounts of 
antiserum was observed. However, total amount of o^M 
associated trypsin activity detectable in the 
immunoprecipitate was about 80% of that lost from the 
supernatant. In presence of various concentration of 
antibody investigated, nearly quantitative loss of <X2^ 
associated trypsin activity from the supernatant was 
observed in presence of 50 pi of antiserum. 
The optimum incubation time for the immunopreclp1 tat ion 
of trypsin transformed o^M was determined by incubating the 
0(2^ trypsin complex with anti-o^M antiserum for various time 
intervals at 10°C. BAPNA hydrolysing activity determined in 
the precipitate showed gradual increase and reached the 
maxima at 6 h (Fig. 16). Further increase in the incubation 
time upto 12 h, did not however, result in further increase 
Figure 15 : Immunoprecipitat ion of a^n Trypsin 
Complexes With Varying Antiserum Concentration 
Alpha-2-macroglobulin was incubated with 2-
ii 
fold molar excess of trypsin at 37°Gi for 15 
-dun-at- pH 8.0. Soyabean trypsin inhibitor (2 
fold molar excess) and varying amounts of 
antiserum was added to the tubes. Thej samples 
were incubated for 8 h at 10!°C and 
centnfuged at 3000 g for 10 min.; BAPNA-lytic 
activity was determined bat*? i-n the 
supernatant and in the precipitate. I Percent 
activity remaining in the supernatant ( • ) 
and that in the precipitate ( o ) was 
calculated using the BAPNA-lytic activity of 
"the 'sample' tO'Whi'ch was'added no antiserum as 
100. 
ADDED ACTIVITY (V.) 
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Figure 16-: Immunoprecipitation of a^n Trypsin Complexes 
at Different Time Intervals 
Alpha-2-macroglobulin trypsin complexes were 
prepared as described in legend to figure 15. 
The samples were incubated with optimum 
amounts of antiserum for different time 
intervals at 10°C. The precipitate was 
centrifuged at 3000 g for 10 min. Percent 
BANA-lytic activity in the supernatant ( • ) 
and that in the precipitate ( o ) was 
determined at different time intervals. 
ADDED ACTIVITY (V.) 
3 
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in BAPNA-lytic activity of the immunoprecIP1tate. 
A clear inverse relationship between the BAPNA-lytic 
activity disappearing from the supernatant and that 
detectable in the immunoprecip1tate was observed after 
incubation for various time intervals. No significant BAPNA 
lytic activity was detectable in the supernatant after six 
hours of incubation. Comparable results were obtained when 
(X2^ containing entrapped nonproteoly t IC enzymes like 
peroxidase and invertase were precipitated with anti-o^^ 
antiserum (data not included). 
QUANTITATION OF HRP AND INVERTASE ENTRAPPED IN ALPHA-2-
MACROGLOBULIN BY IMMUNOPRECIP ITATION PROCEDURE 
Advantage was taken of the anti o^M antiserum to 
quantitatively precipitate the native and the "fast" form of 
0C2M to measure the extent of entrapment of HRP and invertase 
in <X2'V1. Entrapment of the enzymes were performed in a manner 
described above, using soluble as well as matrix linked 
trypsin. Separation of the free enzyme from that entrapped 
in 0(2^ by immunoprecipi tat ion was achieved by the addition 
of optimal amounts of anti o^^ antiserum to oc2,v, enzyme 
mixtures of increasing molar ratio exposed to trypsin. The 
precipitate was assayed for the respective enzyme activity 
which inturn were used to calculate the entrapment yields. 
Figure 17 shows that there is an initial increase in the HRP 
and invertase activity in the respective immunoprecip1tates 
Figure 17 : Effect of Increase in Enzyme: a-^ Molar Ratio 
on the Entrapment of HRP and Inverta^e 
Alpha-2-macroglobulin (1.4 pM) was mixed with 
increasing amounts of HRP or invertase and 
incubated with Sepharose bound trypsin for 2 
h at 37°C with constant and gentle stirring. 
The immobilized trypsin was separated by 
centrifugation and the «2^ enzyme complex was 
precipitated by adding 100\)il of anti o^M 
antiser-ura. The sample were intubated for 8, h 
• • - - , \ 
and centnfuged* HRP activi£y\ ( • ) and 
invertase activity ( o ) in the precipitate 
were determined. 
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when the molar ratio of the two enzymes was increased from 
1.5 to 3.0. The immunopreclpltate of HRP containing o^M did 
not show further increase in enzyme activity even though the 
enzyme inhibitor ratio was increased to 6:1. Thus, maximum 
entrapment of HRP was observed when enzyme inhibitor ratio 
was 3:1. The immunopreclpitates showed maximum invertase 
activity when invertase was present in 4.5 fold molar excess 
of the inhibitor. Incubation of upto six-fold molar excess 
of enzyme with the inhibitor caused no further increase in 
invertase activity in the immunopreclpitates. The entrapment 
yields of the enzymes obtained (Table 2) from 
immunopreclpltat ion experiments gave some what lower enzyme: 
Cf.^ ratios compared to the values determined after 
separation of o^^ complexes by molecular sieving 
chromatography corraborating the previous observation made 
with trypsin o^M complex. 
PROPERTIES OF ALPHA-2-MACR0GL0BULIN ENTRAPPED ENZYMES 
1. Micheal is—Menten Constant : 
The Michealis Menten constant (Km) for the 0(2^ 
entrapped enzymes, HRP and invertase, were calculated by 
plotting the Line Weaver Burk plot. Respective native 
enzymes were used as controls. 
Figure IB shows that native HRP has a Km of 66 x lo'J 
mM for H2O2 while the Km of 0C2M entrapped HRP was 40 x 10_>J 
mM under identical assay conditions. 
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TABLE - 2 
Soluble or Immobilized Trypsin Mediated Entrapment of HRP 
and Invertase in «2'"'-
Enzyme : o^M molar ratio 
Trypsin preparation HRP Inve rtase 
Soluble 1.2 ND 
1 .0 
1 .4' 
0.3 
ND 
Immob ill zed 1.8 0.8 
1 .6 
1.8" 
0.6 
ND 
ND - not determined. 
Values calculated after removal of the unentrapped enzymes 
by gel filtration. 
b 
Values based on the estimations done in immunopreclpltates 
subsequent to the precipitation with anti 0C2M antiserum. 
Values based on iron estimation after isolation of o^M 
complex by gel filtration. 
Figure 18 : Effect of Substrate Concentration on the 
Native and cn^ Entrapped HRP 
To a series of tubes containing equal amounts of 
native HRP / o.^ entrapped HRP, increasing 
amounts of H2O2 were added. The amount of 
H2O2 cleaved was monitered in presence 
0 Dianisidine at 460 nm. The data was. plotted 
in the form of double reciprocal plot using 
least square analysis. The Km of the enzyme 
was determined by extrapolating the x axis. 
( • ) Native HRP 
( o ) o<2M e n t r a p p e d HRP 
1 
V 
•03 •06 -09 
i i ] x ,0"3mM 
•12 
Figure 19 : Effect of Substrate Concentration on the 
Native and o^M Entrapped Invertase 
Increasing amounts of sucrose was added to 
the tubes containing equal amount of native 
or (X2^ entrapped invertase. The standard 
assay procedure described under methods was 
followed to determine the rate of the 
reaction. The inverse of the rate of the 
reaction was plotted against the inverse of 
substrate concentration of the enzyme using 
least square methods. 
( • ) Native invertase 
( 0 ) o^M Entrapped invertase 
(si m M 
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The Km values of soluble and o^M entrapped invertase 
were also determined in a similar way. The assay procedure 
for invertase was that described under "methods". Figure 19 
shows the Km of soluble invertase as 24 mti while o^ '*1 
entrapped invertase gave a slightly higher value of 60 mM 
using sucrose as substrate. 
2. Immunodiffusion : 
Immunodiffusion was carried out on glass slides 
according to the method described by oLchterlony (1962). 
Native invertase gave clear precipitin lines on 
immunodiffusion (Fig. 20) while 0C2M entrapped invertase did 
not show any indication of immuno reaction under identical 
condi tions. 
IMMOBILIZATION OF ALPHA-2-MACR0GL0BULIN ON CON A SEPHAROSE 
1. Binding to the Lectin Matrix : 
Con A was coupled to the cyanogen bromide activated 
Sepharose by the method of Porath et al. (1967) and the 
immobilized Con A was activated with metal ions. The 
preparation obtained contained 2.5 mg of Con A per gm of 
matrix. A part of the Con A matrix was extensively 
succinylated using succinic anhydride. Over 98'/. of the free 
amino groups present on Con A matrix were succinylated under 
the conditions employed. Both succinylated and non 
succinylated supports were used for immobilization of o^^. 
As evident from Table 5, succ m y 1 at ion of Con A Sepharose 
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TABLE - 3 
Kinetic Parameters of Soluble and a^M Entrapped HRP and 
Invertase 
* 
Enzyme Preparation Km (mM) 
HRP Soluble 40.0 x 10~ 3 
-3 
o^M Entrapped 66.6 x 10 
Invertase Soluble 24.0 
<X2M Entrapped 40.0 
Invertase and HRP activities were determined under standard 
conditions as a function of their respective substrate con-
centrations and Km values were calculated by Lineweaver-
Burk plots using a least square procedure. 
Figure 20 : Immunodiffusion of free and a^ entrapped 
Invertase 
The procedure of Ouchterlony (1962) was 
followed for the determination of cross 
reactivity of free and o^M entrapped 
invertase using rabbit anti-invertase 
antiserum. The central well contained 10 \il 
of invertase antiserum, while wells 2 and 3 
contained 10 and 20 pg native invertase while 
well 4 and well 5 contained 8 pg and 16 jjg of 
0(2^ 1 entrapped invertase. 
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TABLE - 4 
Immobilization of a^M an Lectin Matrix 
oc2M 
S u p p o r t 
Units Units in Units Units 
added Supt. bound bound 
(Theoretical) (Actual) 
Con A Sepharose 330 159 171 86 
Succinylated Con A 330 180 150 63 
Sepharose 
One unit is the p moles of BAPNA hydrolysed per 30 min at 
37"C. The values represent the mean of three independent 
experiments done in duplicate. 
Values determined by subsftract ing the units in the 
supernataht from the units added. 
Values determined on the matrix. 
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slightly improved the binding of «2 M- When tested for 
trypsin inhibitory activity however, o^^ bound on Con A 
Sepharose showed marginally higher values as compared to 
that bound on succinylated Con A (Table 6). There seem to 
exist some masking of the BAPNA-lytic activity of the 
trypsin bound to immobilized 0C2M. While only about 50*/. of 
the activity disappearing from the solution after incubation 
of Con A Sepharose bound o<2M could be detected on the 
matrix, the value was only 40*/. when succinylated Con A 
Sepharose bound o^M was used. 
2. Elution from the Lectin Matrix : 
Elution of 0(21*1 bound to Con A and succinylated Con A 
Sepharose was performed with 0.5 M methyl mannoside. As 
evident from Table 5, somewhat higher amounts of o^ '*' could 
be eluted from Con A Sepharose as compared to that from 
immobilized succinylated derivative. The elution yields were 
60 and 45 percent respectively from succinylated and non 
succinylated Con A. 
ELECTROPHORESIS OF MATRIX ELUTED ALPHA-2-MACROGLOBULIN AND 
ALPHA-2-MACR06L0BULIN TRYPSIN COMPLEX 
The a2^ bound to Con A and succinylated Con A matrices 
were eluted by 0.5 M methyl mannoside and subjected to PAGE 
and SDS-PAGE. Figure 21 shows the e1ectrophoretIC pattern of 
o^M eluted without any further treatment from Con A (lane c) 
and succinylated Con A (lane d) matrices, on 5*/. non-
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TABLE - 5 
Elution of Lectin Matrix Bound o^M 
Con A Sepharose Succmy 1ated Con A 
(Units) Sepharose (Units) 
Activity on Support 171 150 
Activity Eluted 102 68 
Elution C/.) 60 45 
Values represeent the theoretical units. 
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TABLE - 6 
Elution of Trypsinized o^M from Lectin Matrix 
Con A Sepharose Succinylated Con A 
(Units) Sepharose (Units) 
Activity on Support 86 63 
Activity Eluted 36 42 
Elution C/.) 42 67 
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denaturing gels. Electrophoretic mobility of these two o^M 
were identical with native o^M (lane a ) . The Con A and 
succinylated Con A bound 0C2M that were exposed to soluble 
trypsin prior to elution migrated as the "fast" form 
(1ane e, f ) . 
The SDS-PAGE of the o^M preparations bound and eluted 
from Con A matrix with or without exposure to proteinase is 
shown in Figure 22. Lane c and d correspond to o^ 1*1 eluted 
from Con A and succinylated Con A Sepharose matrices and 
shows the 185 KDa subunit similar to native o^M (lane a). 
Matrices bound o^M that were treated with trypsin showed the 
characteristic doublet in VO KDa region that is obtained 
when soluble a2 M 1 S treated with proteinase. Faint bands at 
the lower end of gel (lane b, e and f) appear to be those of 
trypsin. 
Figure 21 : PAGE of a^H Eluted from Lectin Matrices 
Matrix bound o^M eluted with 0.5 M methylman 
oside and electrophoresed on 5'/. gel. Th 
method of Van Leuven (1982) was followed 10p 
of each sample was applied on the gel an 
electrophoresis was performed at 125 V for 
3 h. 
Lane a - Native a^M 
Lane b - o<2M treated trypsin 
Lane c - o<2Meluted from Con A 
Lane d - o<2Meluted from succinylated Con A 
Lane e - Trypsinized a2 M eluted from Con A 
Lane f - Trypsinized o<2M eluted from succiny 
lated Con A. 
a b c d e < 
Figure 22 : SDS-PA6E of ot2M Eluted from Lectin Matrices 
Alpha-2-macroglobulin were eluted from the 
Con A matrix using 0.5 M methylmanoside. The 
eluted protein was denatured in incubating 
at 37°C for 45 min in the sample buffer. Ten 
micrograms of each sample was applied on a 
7.5'/. gel and electrophoresis was performed at 
100 V. 
Lane a - Native o<2M 
Lane b - 0C2M treated trypsin 
Lane c - Con A eluted «2M 
Lane d - Succinylated Con A eluted «2M 
Lane e - Trypsinized o^M eluted from Con A 
Lane f - Trypsinized «2M eluted from succiny-
lated Con A. 

DISCUSSION 
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Alpha-2-Macroglobulin has a unique structure and 
presumably a unique physiological role which are indeed 
challenging and engrossing. Its unusual inhibitory capacity 
results from a conformational change, initiated by the 
proteolytic cleavage (of the inhibitor), that physically 
entraps the causative proteinase (Barrett and Starkey, 
1973). The o^ 1*1 entrapped proteinases are protected from 
interacting with large molecular weight substrates, 
inhibitors and antibodies (Rinderknecht et al., 1970; Miyata 
et al., 1980). The conformational alterations that accompany 
bait region cleavage and proteinase entrapment also expose 
the receptor recognition sites on the molecule that bind, 
with remarkably high affinity, to the specific receptors 
present on fibroblasts (Dickson et al., 1981) hepatocytes 
(Glieman & Davidsen, 1986), macrophages (Feldmen et al.. 
1985; Kaplan & Neilsen, 1979) and monocytes (Straignt et 
al., 1988). The o^M receptor bearing cells recognize and 
rapidly internalize the o<2M proteinase complex by receptor 
mediated endocytosis. Complex formation with proteolytic 
enzymes lowers the circulating half life to 2-4 min which is 
several hundred folds less thanthat(of the native 0C2M (Imber 
and Pizzo, 198I; Feldman et al.,1983). Some reports are also 
available on the attempts of entrapment of proteins and enzymes 
bearing no proteolytic activity in a2M (Osada et al., 1987). 
Specific endocytotic internalization of 0C2M-a~gal ac tosidase 
by the enzyme deficient cultured fibroblast from Fabry's 
if" ^CNo. _ 477 
—t42&tr /; 
patients was demonstrated. The f 1 &T*QjbXa^k^-f'e t a 1 n e d «-
galactosidase activity for several hours (Osada et al.. 
1987). The procedure employed by Osada et al. (1987) 
involving the incubation of &-^\ with a mixture of trypsin 
and a-galactosidase resulted in very low entrapment yield of 
the enzyme. This was presumably related to the preferential 
uptake of the proteinase used for bait region cleavage. 
Using Serratla proteinase, Nakamura et al. (1987) could 
entrap HRP but not SOD in o<2Pl. The later, however, could be 
entrapped by prior conjugation with the proteinase. In the 
present study, exclusive entrapment of the non-proteolytic 
enzymes HRP and invertase in o^^ i n high yield has been 
achieved using Sepharose bound trypsin for the bait region 
c1eavage. 
Extensive work is currently being done on various 
aspects of 0C2M anc* several isolation procedures are 
therefore, available. The most widely used procedure is that 
of Kurecki et al. (1979) that exploits the zinc binding 
property of the inhibitor. Affinity column of zinc was 
prepared using epoxy activated Sepharose and used in 
combination with ammonium sulphate fractionation and gel 
filtration to achieve purification of o^M from blood plasma. 
Other workers have used polyethylene glycol precipitation 
and or gel filtration in combination with zinc affinity 
chromatography (Bjork and Fish, 1982; Vander Graff et al., 
1984; Arakawa et al., 1986). A single step purification 
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scheme based on the affinity of «2^ for the snow drop bulb 
lectin was reported by Shibuya et al. (1988). Cibarcon Blue 
Sepharose, that binds and retards the mobility of most 
plasma proteins other than 0C2M has also been used in 
combination with gel filtration (Virca et al., 1978). 
The purification scheme followed in the present study 
is based on that of Miyata et al. (1981). The procedure 
employs gel filtration in combination with DEAE 
cellulose chromatography. An additional ammonium sulphate 
fractionation proved advantageous in eliminating the 
rechromatographIC steps recommended in the procedure. 
Ammonium sulfate fractionation resulted in two-fold 
purification with a yield of 80'/.. A further 16.5-fold 
purification was achieved on Sephadex G-200 column. 
Fractionation of Sephadex eluate on DEAE cellulose column 
gave an additional 1.7-fold purification with an overall 
yield of 28'/.. The o^M preparation obtained appeared 
homogenous in SDS and non-SDS polyacrylamide gel 
electrophoresis (Fig. 8 and 9) and exhibited the 
characteristic "slow" to "fast" transformation in mobility 
on trypsinization (Barrett et al., 1979; Nelles et al., 
1980) in non-denaturing electrophoresis in 5'/. gels (Fig.11). 
Sepharose bound trypsin was capable of bringing about 
the transformation of o^ 1*1 t o t n e "fast" form (Fig. 11) 
indicating that immobilization process does not abolish the 
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bait region cleaving ability of the enzyme. Higher amounts 
of immobilized enzyme and longer exposure to the inhiDitor 
was, however, required indicating some stenc restriction in 
the cleavage of bait regions. These results are in agreement 
with those of Bjork (1984) who demonstrated that all 
alterations brought about in 0C2M as a result of exposure to 
soluble proteinases including bait region cleavage, and 
cleavage of thiolester bonds can also be induced by the 
immobilized trypsin. Identical nature of 0(2^ 1 transformation 
induced by soluble or immobilized chymotrypsin has also been 
demonstrated by image processing of the electron microscopy 
(Biosset et al., 1991). Huenmann et al. (1989) on the other, 
had observed that when 0C2M was incubated with trypsin 
immobilized an agarose, latex beads and sheep red blood 
cells, varying amounts of the inhibitor was bound to the 
supports. While only 10-20'/. of <X2'V1 was bound by agarose 
linked trypsin, retention of the inhibitor on latex beads 
and sheep red blood cells was quantitative. Reasons for the 
apparently contradictory results of Huenmann et al. (.1989) 
and those of Bjork (1984) and Boisset et al. (1990) and in 
this study are difficult to explain and may be related to 
the types of support used for proteinase immobilization and 
experimental conditions employed. 
Alpha-2-macroglobulin entrapped trypsin could be 
rapidly quantitated using assay procedure of Ganrot (1966) 
that employs SBTI for inhibiting the non-entrapped enzyme. 
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In the absence of the availability of such inhibitor, 
quantitation of HRP and invertase necessiated a gel 
chromatographic separation. Entrapment yields calculated 
using the o^M peak fraction eluting at void volume (Fig. 
12) showed that while it was possible to entrap HRP with a 
molar ratio of 1.2:1 with the help of soluble trypsin, use 
of the insoluble proteinase increased the molar ratio to 
1.8:1 (Table 2 ) . As also observed earlier with several 
proteinases (Gonias and Pizzo, 1983a), the extent of 
entrapment of the nonproteinases appeared to depend upon 
their molecular weight (Table 2 ) . Large molecular weignt 
proteinases, like plasmin, bind to o<2M w l^h a molar ratio of 
1:1 while two molecules of smaller molecular weight 
proteinase are bound by each oc^ M molecule. The large 
molecular dimensions of invertase (Mr 270,000) presumably 
restrict its entrapment and the maximum enzyme : «2^ molar 
ratio achievable with invertase was only 0.8:1 (Table 2 ) . 
In order to eliminate the time consuming gel filtration 
step that also resulted in dilution of the preparation, ana 
rapidly quantitate the o^M associated non proteinase, 
advantage was taken of the anti 0C2M antiserum to nearly 
quantitatively precipitate o^M "from the solution. For this 
purpose antiserum raised in rabbits against highly purifieo 
0(2^ was used. The antiserum was capable of reacting with 
native as well as "fast" form of «2 M a s evident from the 
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precipitin lines observed on immunodiffusion (Fig. 14,'. As 
shown in figure 15, a good correlation was observed between 
the loss of soluble BAPNA hydrolysing activity and increase 
in that of the immunoprecipltate when increasing amount of 
antiserum was added to samples containing o^M entrapped 
trypsin. The BAPNA-lytic activity detectable in the 
precipitates was 80'/. of that disappeared from the solution 
and further increases in incubation time (Fig. 16) or 
antiserum concentration (Fig. 15) did not improve the 
yield. The somewhat low values of BAPNA-lytic activity 
detected in the immunoprecipltate presumably indicate some 
restriction in accessibility of enzyme in the lmmuno-
complexes to the substrate. 
As evident from the figure 17, maximum enzyme 
entrapment was achieved when molar ratio of HRP : o^M was 
3:1 and raising this ratio to 6:1 did not further increase 
the entrapment yield of HRP. However, with invertase the 
maximum entrapment yield could be achieved only when the 
enzyme : inhibitor ratio was 4.5:1, further indicating the 
effects of molecular weight on entrapment. The entrapment 
yields of both the enzymes were as mentioned earlier 
markedly lower when soluble trypsin was used for bait region 
cleavage (Table 2 ) . 
The entrapment yields calculated from immuno 
precipation experiments gave some what lower enzyme : o<2M 
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ratio as compared to the values determined after separation 
of (X2^ complexes by molecular seiving chromatography in case 
of HRP and invertase (Table 2 ) . This corroborates our 
results obtained with 0C2M trypsin complexes which were 
discussed earlier. The enzyme entrapment yields calculated 
in these studies were based on activity measurements of the 
entrapped enzymes as has also been done in some previous 
proteolytic enzyme studies (Gonias et al., 1982b). However, 
few reports suggest that the some o^M entrapped enzymes may 
show somewhat enhanced (Swenson & Howard, 1979) or reduced 
(Rinderknecht et al., 1975) activity, presumably because of 
the effects of environment of the entrapped molecule. To 
corraborate this observation entrapment of HRP was also 
quantitated by measurement of 0C2M associated iron. 
Calculations based on iron estimation are in good agreement 
with those obtained with enzyme activity (Table 2 ) . 
The Km values of the o^M entrapped HRP and invertase 
(Fig. 18 & 19) are comparable with those of the respective 
soluble enzymes (Table 3 ) . Rinderknecht et al. (1975) also 
observed using low molecular weight chromogenic substrate 
that only slight alteration occur in Km values of o^^ 
entrapped trypsin and chymotrypsin. The 0C2M entrapped HRP 
and invertase thus appear to be uneffected by the 
environment and remain highly accessible to their respective 
substrate which happen to be quite low molecular weight. 
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High molecular weight proteinases like plasmin have 
been shown to retain some cross-react 1v1ty with their 
antibodies after 0C2M entrapment (Nilehn and Ganrot, 1967; 
Salvesen and Barrett, 1980). Invertase entrapped in o^M 
however failed to react with its antiserum (Fig. 20). This 
may be related to the extensive glycosy1 at ion of the enzyme 
(Trimble and Maley, 1977). While the possibility of masking 
of antigenic sites of invertase as a result of its 
association with 0C2M without being physically entrapped 
cannot be ruled out, in the absence of more direct 
alternative evidence, lack of reactivity with antibodies has 
been taken as an indication of entrapment (Miyata et al., 
1980). Moreover, as polyclonol antibodies have been used in 
the present study, lack of reactivity of o^M associated 
invertase is even more difficult to envisage by mechanisms 
other than physical entrapment; antisera raised against the 
enzymes are expected to contain antibodies directed against 
various determinants of the enzymes and at least some of 
these will be expected to bind with invertase unless all the 
determinants are completely masked by entrapment. 
Haverback et al. (1962), Ohlsson and Qlsson, (1978; and 
Miyata et al. (1980) have also reported complete masking of 
the antigenic sites of various small molecular weight 
proteinases entrapped in 0C2M. The likelihood of the «2M 
entrapped non-proteinase being non-immunogenIC and non-
antigenic like the entrapped proteinases is quite high. The 
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problem of antigenecity and immunogenecity have, however, 
not been addressed in this study. 
The procedure for the entrapment of non-proteinase 
discussed in the study offers several advantages. Use of 
immobilized trypsin not only increases the entrapment yields 
of non proteinase but also prevents the coentrapment of 
trypsin used for bait region cleavage of o^M• Such 
coentrapment of trypsin, may rapidly lead to the degradation 
of the entrapped nonproteinase. Even if the trypsin and the 
enzymes lacking proteolytic activity are not entrapped in 
the same o^M molecule, separation of «2^ molecules 
containing trypsin from those with entrapped non proteolytic 
enzymes will be extremely difficult. Consequently, any 
attempt to deliver the enzymes to a cell will inevitably 
result in the delivery of trypsin to the target cell. "In 
addition to the potential in enzyme therapy, the o^M may be 
useful as a vehicle for the transport of other 
pharmacological agents including hormones and drug 
conjugated to proteins and other macromolecules. The 
remarkable potential of 0C2M entrapped enzymes in enzyme 
therapy has already been indicated by the work of Osada et 
al. (1987) who successfully delivered oc-gal ac tosidase to 
cultured fibroblasts derived from Fabry's patients. 
Macrophages have been shown to contain receptors for the 
protease transformed o^Ms (Feldman et al., 1985; Kaplan and 
Neilsn, 1979). Since some of the macrophages are involved in 
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the habouring of parasites like the Leishmania (Mukhopadhyay 
et al., 1989), 0C2M may prove to be extremely useful in the 
targetted delivery of toxic proteins or protein conjugated 
small molecular weight drugs in parasitic disorder 
afflicting the macrophages and other cells bearing receptors 
for 0(2^. 
Recent studies suggest that o^M receptor is identical 
to LRP (Strickland et al., 1990). Since LRP is present on 
the surface of many cells, it should be possible to 
conveniently introduce bioactive proteins and peptides in 
such cells for studying their influence on the lipoprotein 
uptake and catabolism. Infact it appears clear that «2 M 
receptors may be involved in functions other than catabolic, 
including protein secretion, antigen processing, and 
activation of respiratory burst by phorbol esters (Hoffman 
et al., 1983, 1987; Johnson et al., 1982). Understanding of 
these processes should become convenient with the 
availability of a technique for incorporation of proteins in 
high yields in o^M for possible specific delivery into the 
receptor bearing cells. The technique may also aid in the 
study of cytokine o^^ interaction that are receiving 
considerable attention in recent years (Borth and Lugar, 
1989; Danealpour and Sporn, 1990). 
Using indirect immunofloresence technique, Becker and 
Harpel (1976) demonstrated the presence of oc-,M on surface of 
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endothelial cells in sections of arteries, veins and 
lymphatics. a2^s has also been identified in human platelet 
membrane and granular fractions, but not in the cytoplasm 
(Nachman et al., 1976). Given the broad specificity of «2,v1 
in inhibiting proteinases it is likely that o^M m ay serve as 
a bulwark in protecting the endothelium from a variety of 
potentially injurious plasma and cellular enzymes which are 
released in the circulation during inflammatory and 
hemostatic events. Stein Werblosky (1980) have shown that 
reduction of o^M layer on vascular endothelium increases the 
number of lung metastases in rats. This role of protection 
against metastases, afforded by endothelium bound o^ 1*1' may 
be related to its proteinase inhibiting ability. However, no 
direct evidence is available on the mechanism of proteinase 
inhibition by endothelium bound 0.2^. In order to simulate 
behaviour of endothelium bound o^M» reversible 
immobilization of 0C2M on a proteinic matrix was envisaged. 
For this purpose Con A was selected as 0C2M has been shown to 
bind to the lectin via its glycosyl residues (Ben-Yoseph et 
al., 1979) o<2M was bound on Con A as well as succinylated 
Con A matrices. The yield of immobilization were reasonably 
good (Table IV) and there was no significant difference in 
the binding capacity of the two types of matrices used. The 
«2 M bound on either matrix was capable of inhibiting 
trypsin. However, this inhibitory activity was only 40-50'/. 
of the theontical value. The likely exp 1 ainat ions for the 
87 
low activity of the inhibitor include rigidity of the three 
dimensional structure of the o^M resulting from its 
attachment to several sites on the matrix or its limited 
accessibility to trypsin. The association of 0.2^ with the 
matrix may interfere in the attainment of conformation 
required to completely entrap trypsin thus making trypsin 
susceptible to SBTI inhibit ion or the entrapment is restricted 
due to steric hinderance. However, presence of significant 
SBTI resistant activity on the matrix indicate that atleast 
some of inhibitor molecules are capable of entrapping 
trypsin like the native inhibitor (Table VI). Elution of 
matrix bound 0C2M indicate that the native inhibitor 
molecules are more readily eluted from the lectin matrix 
than trypsin treated o^^5 (Table V) presumably due to 
stronger association of the later with native and 
succinylated Con A. It is well known that trypsimzed or 
fast form of o^M is more compact (Gonias et al., 1982b; 
Bjork and Fish, 1982; Brangegard et al., 1982) and the 
resulting redistribution of the orientation of the glycosyl 
chain may improve its affinity for the lectin. The report 
of Enghild et al. (1989) confirming the presence of 
carbohydrate chain in the thiolester bound loop region and 
in the receptor binding domain that is involved in the 
conformational change further support the argument about 
stronger association of trypsimzed o^ 1*1 f o r C o n A- Native 
PAGE (Fig. 21) shows that the a„M eluted from the lectin 
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matrix after trypsin treatment moved as the "fast" form 
indicating that the bait region cleavage of matrix bound o^M 
was complete. Also in the SDS PAGE profile (Fig. 22) these 
sample showed the 90 KDa band corresponding to the cleaved 
subunit. Since bait region is not glycosylated (Sottrup-
Jensen et al., 1986), its involvement with the binding of 
0(2^ to Can A matrix can be eliminated. Also, bait region is 
suggested to loop out from the o<2Pl structure and is a highly 
accessible and exposed region (Gettins et al., 1988; Gettins 
and Cunningham, 1986). It is thus anticipated that in the 
immobilized state the bait region of o^M is fully accessible 
for proteinase attack. Complete transformation to the "fast" 
form and nearly quantitative cleavage of the bait region of 
o^M eluted from the lectin matrix subsequent to 
trypsinIzation, suggests total transformation of the bound 
molecules. The low trypsin binding activity observed on the 
o^M bound to ConA matrices, however, appear contradictory to 
these observations. The low activity of 0*2^  in the 
immobilized state may be related to the fixation of the 
molecule due to its binding at several places on the support 
such that the molecule cannot undergo complete 
conformational alterations. This may cause either decreased 
entrapment of the proteinase or binding of the proteinase 
such that it continues to remain susceptible to SBTI. The 
molecules are however expected, once released from the 
support, to complete the conformational alteration to the 
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"fast" form. Roche et al. (1988) have similarly observed the 
0C2M crosslinked with cis DDP undergoes proteolytic cleavage 
but no conformational alterations and complete 
conformational change takes place only after chelation of 
cis DDP with DDC. 
The observation that bait region cleavage with 
significant trypsin inhibition by immobilized o^M takes 
place indicates that 0C2M in the immobilized state may be 
capable of inhibiting proteinase though not as effectively 
as the soluble o^M- The speculation that o^M bound to 
surface of endothelial cells act to control proteolysis is 
further supported by this study. The nature of association 
of c^M with endothelial cells may be completely different 
from that with Con A, and may facilitate the expression of 
full activity of the inhibitor. 
SUMMARY 
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Human alpha-2-macroglobulin (o^M) is a large (720KDa> 
tetramenc glycoprotein which has evolved into a wide 
spectrum inhibitor of virtually all endoproteinases 
regardless of their specificity or catalytic mechanism. It 
is unusual in its ability to prevent proteolysis without 
direct blockage of their active sites. The unique steric 
mode of proteinase binding by o^M is made possible by a 
series of molecular events, starting with proteolysis at the 
sequence of residues termed the bait-region which results in 
the cleavage of thiol esters. Thiol ester cleavage produces 
a large conformational change and the concamitant entrapment 
of the proteinase molecule. Also, receptor recognition site 
that facilitates the binding of o^M-proteinase to the cell 
surface receptors are unmasked during conformational change. 
The proteinase are entrapped in active form but are 
stencally prevented from acting on large molecular weight 
substrates. Preliminary reports indicate that non-
proteolytic enzymes may also be entrapped with retention of 
their catalytic activity. Since the antigenecity of a2 M 
entrapped enzyme is masked and is rapidly internalized by 
receptor bearing cells, o^M seems promising in the in vivo 
delivery of enzymes. 
Human o^ '"' w a s purified from outdated blood in a three 
step procedure. The proteins were precipitated between 20-
40*/. ammonium sulphate saturation and chromatographed on 
Sephadex G-200 column. This resulted in 33-fold purification 
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with 50'/. yield. DEAE-ce1lulose chromatography resulted in an 
el ectrophoret ical ly homogenous 0C2M preparation with 56-fold 
purification and 28*/. yield. The preparation showed the 
characteristic "slow" to "fast" shift upon trypsin 
treatment, as evident from migration in non-denaturing gels. 
Immobilized trypsin also transformed the "slow" form to 
"fast" form. 
Entrapment of Horse radish peroxidase CHRP) and 
invertase was achieved using soluble as well as immobilized 
trypsin. The enzyme : inhibitor ratios were 1.2:1 and 0.3:1 
for HRP and invertase respectively when soluble trypsin was 
used for bait region cleavage. These ratios were however 
1.8:1 and 0.8:1 for HRP and invertase when entrapment was 
performed in presence of immobilized trypsin. An 
immunopreclp11at 1 on assay was developed using anti o^M 
antiserum to precipitate o^M enzyme complexes. It reveals 
that maximum HRP entrapment could be achieved when the 
enzyme is in 3-fold excess in molar ratio to inhibitor while 
maximum invertase entrapment was achieved with an enzymes 
molar excess of 4.5 to that of inhibitor concentration. 
Entrapment yields of non-proteolytic enzymes were generally 
calculated by measuring enzyme activity associated with the 
inhibitor. However, in case of HRP, the entrapment was also 
quantitated by iron estimation. The values calculated on the 
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basis of iron estimation were in good agreement with those 
obtained by enzyme activity measurements. 
The entrapped enzymes were free to express their 
activity as evident from their relative unaltered Km values. 
The 0(2^ entrapped invertase failed to give precipitin line 
on immuno-diffusion suggesting that the antigenic sites of 
the enzymes are masked, presumably by physical entrapment. 
Earlier reports reveal that o^^ coats the surface of 
endothelial cells probably to protect it from proteinases. 
In order to simulate the behaviour of endothelium bound o^M, 
reversible immobilization of 0(2^ was performed on Con A 
Sepharose matrix. Reasonably good amount of inhibitor was 
found to bind on the matrix. The activity of the proteinase 
on the support was only 40-50'/. of the bound. Elution of the 
lectin matrix immobilized o^M was incomplete and decreased 
further subsequent to trypsin treatment. ElectrophoretIC 
patterns of the eluted inhibitor reveal that trypsin 
treatment of immobilized o^M cleaves the bait region 
completely and transforms the molecule to fast form. 
However, the o<2M bound and eluted from the lectin matrix 
without exposure to trypsin showed neither bait region 
cleavage nor alteration in the e1ectrophoretic mobility. 
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Entrapment in human a2-macroglobulin (a2M) of non-
proteolytic enzymes was achieved with the help of tryp-
sin covalently attached to the Sepharose matrix. While 
it was also possible to achieve entrapment by the expo-
sure of the a2M: enzyme mixtures to soluble trypsin, use 
of the immobilized proteinase resulted in improved en-
trapment yields and also prevented the coentrapment of 
trypsin. Both soluble and immobilized trypsin trans-
formed a2M to the electrophoretically fast form but the 
immobilized trypsin required relatively longer incuba-
tion to bring about the transformation. Horseradish 
peroxidase was entrapped in higher yield in a2M com-
pared to the relatively high-molecular-weight inver-
tase. a2M-entrapped peroxidase and invertase ap-
peared highly accessible to their respective substrates, 
as evident from their relatively unaltered Km values. 
<x2M-associated invertase, in spite of its large dimen-
sions, failed to crossreact with the rabbit anti-invertase 
antiserum, indicating its physical entrapment rather 
than any other form of association, e 1993 Academic 
Press, Inc. 
a2-Macroglobulin (a2M)2 is a major, high-molecular-
weight glycoprotein of blood plasma that functions as a 
broad-spectrum inhibitor of proteinases (1,2). The 
unique inhibition process is initiated by the limited pro-
teolysis of the "bait region" of the a2M, involves cleav-
age of the thiol ester linkages, and results in a large 
conformational alteration accompanied by the physical 
entrapment of the proteinase (2-4). The entrapped pro-
teinases are physically protected from interacting with 
1
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 Abbreviations used: a2M, alpha-2-macroglobulin; HRP, horserad-
ish peroxidase; SBTI, soyabean trypsin inhibitor; PMSF, phenyl-
methylsulfonyl flouride; BAPNA, benzoyl-DL-arginine-p-nitroana-
lide; SDS, sodium dodecyl sulfate; DNS, dinitrosalicylic acid; LRP, 
low-density lipoprotein receptor-related protein. 
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high-molecular-weight substrates, inhibitors, and anti-
bodies (5,6). The proteinases, however, remain active 
and retain their ability to interact with low-molecular-
weight substrates, inhibitors, and other compounds (6-
8). The conformational alterations that accompany bait 
region cleavage and proteinase entrapment also expose 
the receptor recognition sites that bind with high affin-
ity to the specific receptors present on fibroblasts (9), 
hepatocytes (10), macrophages (11,12), and monocytes 
(13). The receptor-bearing cells have been shown to rap-
idly internalize the transformed a2M by the process of 
receptor-mediated endocytosis (14,15). 
Some reports have provided evidence for the entrap-
ment of proteins and enzymes bearing no proteolytic 
activity along with proteinases in a2M (16,17). Since 
most a2M-entrapped proteins neither act as antigens 
nor interact with preformed antibodies and are specifi-
cally internalized by the receptor bearing cells, the po-
tential of a2M as a carrier of enzymes for enzyme ther-
apy has been envisaged. Osada et al. (17) demonstrated 
the specific endocytotic internalization of a2M-a-galac-
tosidase by the cultured fibroblasts from Fabry's pa-
tients and the fibroblasts were shown to exhibit a-galac-
tosidase activity for several hours. The procedure 
employed by Osada et al. (17) involved the incubation of 
a2M with a mixture of trypsin and a-galactosidase and 
resulted in very low entrapment yield of the enzyme. 
Several proteinases, however, can be entrapped with 
enzyme:a2M ratios of 2:1 (18,19). The low entrapment 
of a-galactosidase was presumably related to the prefer-
ential uptake of the proteinase used for bait region cleav-
age. Using the Serratia proteinase, Nakamura et al. (16) 
could entrap HRP but not superoxide dismutase in a2M. 
The latter, however, could be entrapped by prior conju-
gation with proteinase. A convenient strategy for the 
exclusive entrapment in high yields of enzymes that do 
not exhibit proteolytic activity is described in this re-
port. Bait region cleavage of a2M was achieved using 
Sepharose-bound trypsin. Several enzymes with widely 
differing molecular weights, including HRP and inver-
133 
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tase, were entrapped in a2M in high yields in active form 
with the help of immobilized trypsin. 
EXPERIMENTAL PROCEDURES 
Materials. Sephadex G-100, Sepharose 4B, SBTI, 
HRP, invertase, and trypsin were obtained from Sigma 
Chemical Co., U.S.A. 
Purification of a2M. a2M was purified by the method 
of Miyata et al. (20) with some modifications. The 
plasma proteins were precipitated between 20 and 40% 
ammonium sulfate saturation and chromatographed on 
a Sephadex G-200 column followed by ion exchange col-
umn chromatography on DEAE-cellulose. The prepara-
tion so obtained was homogenous in polyacrylamide 
gels run in the presence or absence of SDS. 
a2M assay. a2M activity was measured as its ability 
to protect the trypsin esterase activity from SBTI, as 
described by Ganrot (7). 
Electrophoresis. PAGE was performed on 5% gel as 
described by Van Leuvan et al. (21) using a discontinous 
buffer system. 
Immobilization of trypsin on Sepharose 4B. Sepha-
rose 4B was activated as described by Porath et al. (22). 
Trypsin in 0.1 M bicarbonate buffer, pH 8.5, was stirred 
with the cynogen bromide-activated Sepharose for 24 h 
at 4°C. The trypsin-bound matrix was washed thor-
oughly with 0.1 M bicarbonate buffer, pH 8.5, containing 
1.0 M NaCl. Enzyme-bound Sepharose was then treated 
with 98% ethanolamine for 2 h at 4°C. The matrix was 
again washed successively with 0.1 M bicarbonate 
buffer, pH 8.5, containing 1.0 M NaCl, distilled water, 
and 0.1 M acetate buffer, pH 4.5. The matrix so obtained 
contained 8 mg bound trypsin per gram Sepharose. 
Enzyme assays. HRP was assayed by measuring the 
rate of oxidation of O-dianisidine by H 2 0 2 using the two 
substrates in saturating concentration (23). Invertase 
activity was measured by the method of Goldstien and 
Lampen (24). The glucose liberated at 37°C was, how-
ever, measured by the procedure of Bernfield (25) using 
DNS reagent prepared as described by Sumner (26). 
Quantitation of enzyme entrapment in a2M. Prior to 
determination of enzyme activity, soluble trypsin was 
inhibited by excess SBTI, while the immobilized trypsin 
was removed by centrifugation. a2M complexes were 
separated from the free enzyme either by gel filtration 
on Sephadex G-100 (in the case of HRP) or Sephadex 
G-200 (in the case of invertase) or by immunoprecipita-
tion with specific anti-a2M antisera. The antisera were 
raised in albino rabbits against electrophoretically pure 
a2M by injecting 200 ng of a2M along with Freund's ad-
juvant subcutaneaously. Two weeks later 200 ng more of 
a2M was injected in Freund's incomplete adjuvant, and 
the animals were bled after an additional period of 3 
weeks. The antiserum was capable of reacting with na-
tive as well as transformed a2M as evident from the 
formation of precipitin lines on immunodiffusion (29). 
a2M exposed to soluble or immobilized trypsin in the 
abscense or presence of other enzymes was precipitated 
by the addition of an optimum amount of antiserum. 
About 50 n\ of antiserum was capable of achievable 
nearly quantitative precipitation of 300-350 /ug of a2M 
in a total volume of 3.0 ml containing 20 mM phosphate 
buffer, pH 8.0. The extent of entrapment of various en-
zymes in a2M was calculated by measuring enzyme activ-
ity of the complex and assuming that the entrapment 
process results in no major alteration in the enzyme 
activity. Entrapment activity was converted to mole of 
enzymes using specific activity of the enzyme prepara-
tion. In case of HRP entrapment was also quantitated 
by measuring «2M associated iron. «2M concentration 
was determined by procedure of Lowry et al. (27). 
Iron estimation. Iron estimation was essentially 
done as described by Oser (28). The sensitivity of the 
procedure was improved by performing the assay in a 
total volume of 1.3 ml. 
RESULTS 
Entrapment of enzymes in a2M. Entrapment of en-
zymes lacking proteolytic activity in a2M was attempted 
with the help of either soluble or Sepharose-bound tryp-
sin. For this purpose, a fivefold molar excess of HRP 
was mixed with a2M and the mixture incubated with 
either soluble or immobilized trypsin. To the prepara-
tion containing soluble trypsin was added excess SBTI 
to inhibit free trypsin, while immobilized trypsin was 
removed by centrifugation. Figure 1 shows the elution 
profile of the a2M exposed to either soluble or immobi-
lized trypsin in the presence of HRP. Samples of native 
a2M and HRP were also passed through the column for 
comparison. Both native and trypsin-transformed a2M 
were excluded from the Sephadex G-100 and eluted at 
the void volume of the column. HRP emerged from the 
column with an elution volume of 125 ml and the peak 
was clearly separated from that of a2M. Two protein 
peaks were obtained in the sample treated with soluble 
trypsin; the first, eluting at the void volume, contained 
both HRP andBAPNA-hydrolyzingactivity andthe sec-
ond peak was that of HRP. Only a trace amount of H R P 
was associated with a2M when the two were incubated 
in the absence of trypsin (data not included), clearly 
indicating the proteolysis dependence of the HRP asso-
ciation with a2M.. 
In the samples treated with immobilized trypsin the 
fraction of HRP eluting in the void volume almost dou-
bled, yet no BAPNA-hydrolyzing activity could be de-
tected in the fractions. This suggests that the observed 
effect of immobilized trypsin was not caused by the 
leaching of small amounts of trypsin and consequent 
cleavage of a2M. a2M exposed to either soluble or im-
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FIG. 1. Entrapment of HRP in a2M. A Sephadex G-100 column (1.7 X 90 cm) was packed and equilibrated with 20 mM phosphate buffer, pH 
8.0. Void volume of the column was determined by studying the elution volume of blue dextran. Samples containing pure a2M or peroxidase or 
their mixtures treated with either soluble or Sepharose-bound trypsin were passed through the column under identical conditions and the 
column monitored for HRP (•) and BAPNA-lytic (X) activity as well as protein (O). Elution profiles of (A) pure a2M and (B) HRP. The 
elution profile of a2M incubated with fivefold molar excess HRP in the presence of trypsin (twofold molar excess) for 15 min at pH 8.0 is given 
in (C). (D) Elution profile of a 2 M-HRP mixture incubated as in (C) except that Sepharose-bound trypsin (sevenfold molar excess) replaced the 
soluble enzyme and the sample was incubated for 2 h. 
mobilized trypsin under the conditions described was 
clearly transformed to the fast form (Fig. 2), indicating 
bait region cleavage and accompanying conformational 
alterations (2,3,20,30). 
In order to investigate the extent of incorporation of 
nonporteolytic enzymes in a2M, we took advantage of 
the ability of antiserum raised against purified a2M to 
quantitatively precipitate both the native and the fast 
form of «2M. Separation of free enzyme from that en-
trapped in a2M by immunoprecipitation was convenient 
as it was less time consuming than gel nitration and 
resulted in no dilution of the preparation. In the pres-
ence of the antibody all a2M-entrapped enzyme activity 
disappeared from the solution; only about 80% of the 
136 MIRZA AND SALEEMUDDIN 
FIG. 2 . Electrophoresis of native and trypsin-transformed a2M in 
nondenaturing polyacrylamide gels. Purified a2M was incubated with 
twofold molar excess of trypsin for 10 min at 37°C or with sevenfold 
molar excess of Sepharose-bound trypsin for 2 h, also at 37°C. Solu-
ble trypsin was inactivated by addition of 1 mM PMSF while the im-
mobilized trypsin was removed from the reaction mixture by centrifu-
gation. Ten micrograms of protein was applied in each lane, (a) 
Native a2M, (b) a2M incubated with soluble trypsin, and (c) a2M incu-
bated with immobilized trypsin. 
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FIG. 3 . Effect of increase in enzyme: a2M molar ratio on the en-
trapment of HRP and ivertase. a2M (1.4 fiM) was mixed with increas-
ing amounts of HRP or invertase and incubated with Sepharose-
bound trypsin as described in the legend to Fig. 1. The immobilized 
trypsin was separated by centrifugation and the «2M enzyme complex 
was immunoprecipitated by adding 100 ^1 a2M antiserum. The sam-
ples were incubated for 8 h and centrifuged at 3000g for 10 min. HRP 
activity (•) and invertase activity (O) in the precipitate were deter-
mined. 
total activity lost from the supernatant could be de-
tected in the precipitate, presumably indicating restric-
tion in accessibility of enzyme to the substrate. 
Figure 3 shows that increasing the molar ratio of en-
zyme to a2M during the incubation with immobilized 
trypsin results in a marked increase in the entrapment 
of HRP and invertase. Maximum entrapment was 
achieved when the molar ratio was 3.0 and raising the 
ratio to 6.0 did not further increase the entrapment 
yields. The maximum enzyme:a2M molar ratio achiev-
able with invertase was 0.8, while with HRP it was 1.8. 
Invertase is about six times larger in molecular weight 
than HRP (31) and large molecular dimensions of the 
enzyme presumably restrict its entrapment in high 
yields. The entrapment yields calculated from immuno-
precipitation experiments gave somewhat lower en-
zyme:a2M ratios compared to the values determined 
after separation of a2M complexes by molecular sieving 
chromatography in the case of HRP and invertase (Ta-
ble 1). Comparable enzyme:a2M ratios indicating en-
hanced entrapment of enzymes in the presence of im-
mobilized trypsin were obtained even when the 
entrapped HRP was quantitated by iron estimation. 
The possibility of modification of entrapped enzyme ac-
tivity in the preparations obtained using soluble and 
immobilized trypsin as the cause of observed differences 
in entrapment can thus be eliminated. The entrapment 
yields of the enzymes were markedly lower when soluble 
trypsin was used for the bait region cleavage (Table 1). 
Properties of the a2M-associated enzymes. a2M-en-
trapped HRP and invertase appeared relatively free to 
express enzyme activity. As evident from Table 2 there 
was only a slight increase in the Km value of the en-
TABLE 1 
Soluble or Immobi l ized T r y p s i n - M e d i a t e d E n t r a p m e n t 
of H R P a n d Inve r t a se in a 2 M 
Enzyme:a2M molar ratio 
Trypsin preparation 
Soluble 
Immobilized 
HRP 
1.2° 
1.06 
1.4C 
1.8° 
1.66 
1.8C 
Invertase 
ND 
0.3° 
ND 
0.8° 
0.66 
ND 
Note. Entrapment was performed as described in the legend to Fig. 
1. ND, not determined. 
° Values calculated after removal of the unentrapped enzymes by 
gel filtration. 
6
 Values based on the estimation done in immunoprecipitates sub-
sequent to the precipitation with excess anti-a2M antiserum. 
c
 Values based on iron estimation after isolation of a2M complex by 
gel filtration. 
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TABLE 2 
Kinetic Parameters of Soluble and a2M-Entrapped HRP 
and Invertase 
Enzyme 
HRP 
Invertase 
Preparation 
Soluble 
a2M entrapped 
Soluble 
a2M entrapped 
Km (mM)° 
40.0 X 10"3 
66.6 X 10"3 
24.0 
40.0 
V b 
' max 
(per microgram 
protein/minute) 
416 
406 
ND 
ND 
Note. <XjM containing entrapped invertase/HRP was prepared us-
ing immobilized trypsin and isolated as described in the legend to Fig. 
1. ND, not determined. 
° Invertase and peroxidase activities were determined under stan-
dard conditions as a function of their respective substrate concentra-
tions and Km values were calculated by Lineweaver-Burk plots using 
a least squares procedure. 
b
 The amount of peroxidase entrapped was determined by iron anal-
ysis. 
trapped invertase and HRP compared to that of the re-
spective soluble enzymes. However, even the a2M-en-
trapped invertase, in spite of its high molecular weight, 
was incapable of crossreacting with specific anti-inver-
tase antiserum under conditions in which native inver-
tase showed clear precipitin reaction on immunodiffu-
sion. The lack of reactivity of a2M-associated invertase 
may not be related to the inability of the complex to 
enter the Ouchterlony gel. Invertase a2M complexes 
give clear precipitin reaction against anti-a2M anti-
serum (unpublished data). 
DISCUSSION 
The usefulness of immobilized trypsin in the entrap-
ment of nonproteolytic enzymes in a2M is clearly 
evident from these studies. The entrapment yields cal-
culated in the studies were based on activity measure-
ments of the entrapped enzymes as has also been done 
in some previous proteolytic enzyme studies (30). How-
ever, reports are available that suggest that the enzymes 
entrapped in a2M may show somewhat enhanced (32-
34) or reduced (40) activity, presumably because of ef-
fects of the environment of the entrapped molecule. 
While the possibility of such effects on the activity of 
a2M-entrapped enzymes in the presence study cannot 
be ruled out, the use of immobilized trypsin caused a 
very clear increase in entrapment yields over those ob-
tained with soluble proteinase. In the case of HRP, how-
ever, entrapment calculations based on iron estimation 
also showed a marked increase when immobilized tryp-
sin was used. This suggests the usefulness of immobi-
lized trypsin in increasing the entrapment yields of non-
proteolytic enzymes. In addition, use of immobilized 
trypsin prevented the entrapment of the proteinase in 
a2M (Fig. 1). Coentrapment of the trypsin used for bait 
region cleavage of a2M for the entrapment of nonpro-
teolytic enzymes may result in the degradation of the 
entrapped enzyme by the proteinase. Even if the trypsin 
and enzymes lacking proteinase activities are not en-
trapped in the same a2M molecule, the separation of 
a2M molecules containing trypsin from those contain-
ing nonproteolytic enzymes will be extremely difficult. 
Consequently, any attempt to deliver the enzymes to a 
cell will inevitably result in the delivery of trypsin as 
well. While it is possible to inhibit a2M-entrapped tryp-
sin using low-molecular-weight trypsin inhibitors like 
TLCK, the inhibitor will, in such instances be delivered 
along with a2M to the target cell. 
Whether the association of the entrapped enzyme 
was covalent (38) was not addressed in these studies, yet 
our unpublished data indicate that almost all of the en-
trapped HRP is retained by the complexes prepared us-
ing immobilized trypsin for over 2 weeks at 4°C. Most of 
the a2M-associated enzyme is released in about 1 week if 
HRP is entrapped using soluble trypsin. a2M treated 
with immobilized trypsin appeared indistinguishable in 
electrophoretic mobility from that exposed to soluble 
trypsin (Fig. 2). Bjork (35) in an earlier study also dem-
onstrated that all the alterations brought about in a2M 
as a result of exposure to soluble proteinase, including 
bait region cleavage and cleavage of thiol ester, are also 
caused by immobilized trypsin. Image processing of the 
electron micrographs of a2M transformed by soluble or 
immobilized chymotrypsin also indicated that both mol-
ecules are almost identical (36). Thus, a2M exposed to 
soluble or immobilized trypsin may be indistinguishable 
and hence the latter may be used to deliver the en-
trapped protein in a2M receptor-bearing cells both in 
vivo and in vitro. 
As observed earlier with proteinases, the extent of 
entrapment of nonproteinases was also dependent upon 
their molecular weight. Thus while HRP could be en-
trapped with a molar ratio of nearly 2, (Table 1) those 
obtained with invertase were not more than 1. Although 
high-molecular-weight proteinases like plasmin have 
been shown to retain some crossreactivity with their an-
tibodies after a2M entrapment (37,38), no crossreacti-
vity was observed when invertase entrapped in a2M was 
incubated with the antiserum. This may be related to 
the extensive glycosylation of the enzyme (39) and the 
nature of antibodies used. While the possibility of 
masking of antigenic sites during the association of in-
vertase with a2M without being physically entrapped 
cannot be ruled out, in the absence of the availability of 
alternative procedures a lack of reactivity with antibod-
ies has been taken as an indication of entrapment. More-
over, as polyclonal antibodies have been used in the 
present study, lack of crossreactivity of a2M-associated 
invertase is even more difficult to envisage by mecha-
nisms other than physical entrapment. Antisera raised 
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against the enzymes are expected to contain antibodies 
directed against various determinants of the enzymes 
and at least some of these will be expected to bind with 
invertase if it is not completely entrapped. 
The a2M-entrapped nonproteinases appear to be free 
to exhibit their activity and remain highly accessible to 
their substrates as evident from the relatively unaltered 
Km values (Table 2) as has been observed with several 
proteases (6). a2M receptor occurs in many types of cells 
(9-13) and transport of a2M-entrapped galactosidase in 
active form in the cultured fibroblasts of Fabrys' pa-
tients has been demonstrated (17). In addition to the 
potential in enzyme therapy, the a2M may be useful as a 
vehicle for the transport of other pharmacological 
agents including hormones and drugs conjugated to 
proteins. Although hepatocytes may be primarily in-
volved in the elimination of the transformed tv2M, a 
fraction of these may be taken up locally by the macro-
phages (11,12). Since some macrophages may be in-
volved in the harboring of parasites like the Leishmania 
(40), a2M may be useful as a vehicle for the specific 
delivery of toxic proteins and other conjugated agents 
for such therapy in a safer form. 
Recent studies suggest that a2M receptor is identical 
to LRP (41). Since LRP is present on the surface of 
many cells (41) it should be possible to conveniently 
introduce bioactive proteins and peptides in such cells 
for studying their influence on the lipoprotein uptake 
and catabolism. In fact it appears quite clear that a2M 
receptors may be involved in functions other than cata-
bolic, including protein secretion, antigen processing, 
and activation of respiratory burst by phorbol esters 
(42-44). Understanding the mechanism of these pro-
cesses should become convenient with the availability of 
a technique for the incorporation of proteins in high 
yields in a2M for possible specific delivery into the re-
ceptor-bearing cells. The technique may also aid in the 
study of cytokine tv2M interactions that are receiving 
considerable attention in the recent years (45,46). 
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